Start main page content

Journal articles

Wits IDORI is a recognised research institute of Wits University and a Division of the Wits Health Consortium. Our researchers regularly publish their research in peer-reviewed academic journals. Whilst the list below is not exhaustive, it gives an indication of the type of work that is carried out by our team:

2026

  1. Beyrer, C., Ratevosian, J., Carpino, T., Rosenberg, N.E., Gelderblom, H.C., Sullivan, P.S., Deeks, S.G. and Gray, G.(2026), The HIV/AIDS response as we knew it is over: Where do we go from here?. J Int AIDS Soc., 29: e70077. https://doi.org/10.1002/jia2.70077
  2. Calvey, T., Govender, D., Owen, G., Tumba, N., Lang, D., Lerer, B., Stein, D., & Shoptaw, S. (2026). Neurorestorative properties of ibogaine: Linking multi-receptor affinities to remyelination and metabolic restoration. Acta Neuropsychiatrica, 1–36. https://doi.org/10.1017/neu.2026.10059
  3. Reverley, M., Owen, G., Tumba, N., Olateju, O., & Maseko, B. (2026). VGLUT1 and PSD-95 expression remains stable in the prefrontal and cerebellar cortices of the VPA autism rat model. Developmental Neurobiology. In press. https://doi.org/10.1002/dneu.70018
  4. Velaphi, S., Madewell, Z. J., Tippett-Barr, B., Blau, D. M., Rogena, E. A., Lala, S. G., Mahtab, S., … Madhi, S. A. (2026). Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling. Clinical Infectious Diseases, 82(2):326-336. https://doi.org/10.1093/cid/ciaf098.
Publications 2025
  1. Andrews, L. I. B., Halloran, M. E., Neuzil, K. M., van der Laan, L., Huang, Y., Andriesen, J., Patel, M., Fisher, L. H., Janes, H., Rouphael, N., Walsh, S. R., Theodore, D. A., Tieu, H. V., Sobieszczyk, M., El Sahly, H. M., Baden, L. R., Falsey, A. R., Campbell, T. B., Kelley, C. F., Healy, C. M., Immergluck, L., Luft, B., Hirsch, I., de Bruyn, G., Truyers, C., Priddy, F., Sumner, K. M., Flannery, B., Follmann, D., Gilbert, P. B., & COVID-19 Prevention Network (CoVPN). (2025). Evaluating the test-negative design for COVID-19 vaccine effectiveness using randomized trial data: A secondary cross-protocol analysis of 5 randomized clinical trials. JAMA Network Open, 8(5), Article e2512763. https://doi.org/10.1001/jamanetworkopen.2025.12763
  2. Baillie, V., Dangor, Z., Blau, D. M., Mahtab, S., du Toit, J., Assefa, N., Oundo, J., … CHAMPS Consortium. (2025). Post-mortem study of endemic human coronaviruses (HCoV-NL63, OC43, 229E and HKU-1) in deaths of children under five in low- and middle-income countries: Findings from the Child Health and Mortality Prevention Surveillance (CHAMPS) study. Journal of Clinical Virology, 178, 105804. https://doi.org/10.1016/j.jcv.2025.105804
  3. Bakamutumaho, B., Juma, J., Clancey, E., Nyakarahuka, L., Situma, S., Odinoh, R., Dawa, J., Nasimiyu, C., Eskew, E. A., Balinandi, S., Mulei, S., Kayiwa, J., Klena, J. D., Shoemaker, T. R., Whitmer, S. L. M., Montgomery, J. M., Schieffelin, J., Lutwama, J., Muruta, A., Bosa, H. K., Nuismer, S. L., Oyola, S. O., Breiman, R. F., & Njenga, M. K. (2025). Hyperendemicity of Rift Valley fever in Southwestern Uganda associated with the rapidly evolving lineage C viruses. Journal of Infectious Diseases. Advance online publication. https://doi.org/10.1093/infdis/jiaf417
  4. Banooni, P., Gonik, B., Epalza, C., Reyes, O., Madhi, S. A, Gomez-Go, G. D., Zaman, K., … Picciolato, M. (2025). Efficacy, immunogenicity, and safety of an investigational maternal respiratory syncytial virus prefusion F protein–based vaccine. Clinical Infectious Diseases. Advance online publication. https://doi.org/10.1093/cid/ciaf033
  5. Barsosio, H. C., Bont, L. J., Groome, M. J., Karron, R. A., Kragten-Tabatabaie, L., Madhi, S. A., Martinón-Torres, F., Pecenka, C., & Zar, H. J. (2025). How Gavi support for RSV immunisation will advance health equity. The Lancet, 406(10499), 127–128. https://doi.org/10.1016/S0140-6736(25)01117-1
  6. Berkley, J. A., Walson, J. L., Gray, G., Russell, F., Bhutta, Z., Ashorn, P., Norris, S. A., Adejuyigbe, E. A., Grais, R., Ogutu, B., Zhang, J., Chantada, G. L., Nachman, S., Kija, E., Jehan, F., Giaquinto, C., Rollins, N. C., & Penazzato, M. (2024). Strengthening the paediatric clinical trial ecosystem to better inform policy and programmes. The Lancet Global Health, 12(12), e199–e204. https://doi.org/10.1016/S2214-109X(24)00511-4
  7. Bhiman JN, Madzorera VS, Mkhize Q, Scheepers C, Hermanus T, Ayres F, Makhado, Moyo-Gwete T, Crowther C, Singh B, Fortuin M, Marinda E, Jooste S, Zuma Khangelani, Zungu N, Morris L, Puren A, Simbayi L, Moyo S, Moore PL. (2025) Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern. Scientific Reports, 15(1):5549
  8. Bhiman JN, Serwanga J, Ugwu CA, Vigan-Womas I, Wuashie PK, Bhattacharya J, Sande C, Bonomo A, Markey FB, Awandare GA, Garg PK, Kaleebu P, Happi C, the FIISER network, Rennergarble A, Woods C, Kirchner J, Aguilar AO, Maker K, Moore PL. Retaining African Networks is urgent for African and Global Health. Trends in Microbiology (In press) 
  9. Bisanzio, D., Bosa, H. K., Bakamutumaho, B., Nasimiyu, C., Atwine, D., Kyabayinze, D., Olaro, C., Breiman, R. F., Njenga, M. K., Mwebesa, H., Aceng, J. R., & Reithinger, R. (2025). Modeling case burden and duration of Sudan Ebola Virus Disease Outbreak in Uganda, 2022. Emerging Infectious Diseases, 31(9), 1829–1832. https://doi.org/10.3201/eid3109.241545
  10. Black, S., Madhi, S. A., & Rappuoli, R. (2025). Artificial intelligence in the development of vaccines for infectious diseases. The Lancet Infectious Diseases. Advance online publication. https://doi.org/10.1016/S1473-3099(25)00497-9
  11. Bloom K, Ely A, Maepa MB, Arbuthnot P. Bridging gene therapy and next-generation vaccine technologies. Gene Ther. 2025 Jan;32(1):4-7. doi: 10.1038/s41434-024-00502-9.
  12. Bloom K. The disparate burden of infectious diseases. Gene Ther. 2025 Jan;32(1):1-3. doi: 10.1038/s41434-024-00501-w.
  13. Bokop, C., Dhar, N, Izu, A., Thaver-Kleitman, J., Prabdial-Sing, N., Ali, M. M., Akaba, G., Barsosio, H. C., Berkley, J. A., Beck, M. M., … Madhi, S. A. (2025). Prevalence of hepatitis B virus infection among pregnant women and cord blood hepatitis B surface antigen positive newborns in sub-Saharan Africa and South Asia. Journal of Clinical Virology, 179, 105826. https://doi.org/10.1016/j.jcv.2025.105826
  14. Bokop, C., Dhar, N., Izu, A., Ali, M. M., Akaba, G., Barsosio, H. C., Berkley, J. A., … Kwatra, G. (2025). Sero-epidemiology of measles immunoglobulin G antibodies among newborns from South-East Asia and sub-Saharan Africa: An observational, multicenter study. International Journal of Infectious Diseases, 154, 107882. https://doi.org/10.1016/j.ijid.2025.107882
  15. Breiman, R. F., Osoro, E., Reithinger, R., Wang, D., Diamond, M., Van Voorhis, W. C., Wasserheit, J. N., Rabinowitz, P. M., Mboup, S., Hemingway-Foday, J. J., de Oliveira, T., Boon, A. C. M., Schieffelin, J. S., Sempowski, G. D., Moody, M. A., Vasilakis, N., Hanley, K. A., Nasimiyu, C., Situma, S., Ngere, I., Kyobe Bosa, H., Nyakarahuka, L., Bakamutumaho, B., Woodson, S. E., & Njenga, M. K. (2025). Importance of outbreak response research in bridging knowledge gaps on emerging infectious diseases. BMJ Global Health, 10(6), Article e018297. https://doi.org/10.1136/bmjgh-2024-018297
  16. Candy, G. P., Masso, Z. F., Mullah, H. B., Thiba, A. P., Dinat, S., Nweke, E. E., Norton, G. R., Woodiwiss, A. J., & Cromarty, A. D. (2025). Identification of multiple cardiotonic steroids in faecal material of untreated humans and rat models of hypertension. SSRN. http://dx.doi.org/10.2139/ssrn.5371110
  17. Carlson, C. J., Mitchell, D., Gibb, R., Stuart-Smith, R. F., Carleton, T., Lavelle, T. E., Lippi, C. A., Lukas-Sithole, M., North, M. A., Ryan, S. J., Shumba, D. S., Chersich, M., New, M., & Trisos, C. H. (2025). Health losses attributed to anthropogenic climate change. Nature Climate Change, 15(10), 1052–1055. https://doi.org/10.1038/s41558-025-02399-7
  18. Chege GK, Chapman RE, Keyser AT, Adams CH, van Diepen MT, Douglass N, Lambson B, Hermanus T, Moore PL, Williamson A. (2025) Heterologous immunization with improved HIV-1 subtype C vaccines elicit Tier 2 neutralizing antibodies with rapid viral replication control after SHIV challenge. Viruses, 7(2), 277 
  19. Chimukuche, R. S., Shandu, L., Zulu, S., Khanyile, P., Singh, N., Gaffoor, Z., Kawuma, R., McCormack, S., Seeley, J., & PrEPVacc Study Group. (2025). HIV risk perception, trust and PrEP adherence among participants in an HIV prevention trial: a qualitative longitudinal study, South Africa. BMJ Open, 15(2), Article e086742. https://doi.org/10.1136/bmjopen-2024-086742
  20. Chissumba, R. M., Kwatra, G., Ramgi, P., Enosse, M., Sigaúque, A., Khosa, C., Viegas, E., … SIVCOV study group. (2025). Hybrid immunity in a Mozambican cohort after 1 or 2 doses of the BBIBP-CorV vaccine. Clinical Infectious Diseases, 80(Suppl. 1), S57–S65. https://doi.org/10.1093/cid/ciaf095
  21. Cohen C and Moore PL (2025). Maternal Inflammation Likely Drives Impaired Immune Responses to Respiratory Syncytial Virus in HIV-Exposed Uninfected Infants. Journal of Infectious Diseases. Editorial. (Online ahead of Print)
  22. Cohen P, Lambson BE, Mkhize NN, Moodley C, Yssel AEJ, Moyo-Gwete T, York T, Gwashu-Nyangiwe A, Ndabambi N, Thebus R, Juraska M, deCamp AC, Williamson BD, Magaret CA, Gilbert PB, Westfall D, Deng W, Mullins JI, Morris L, Williamson C, Moore PL. (2025) Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross resistance. Journal of Virology, 99(2):e0173024
  23. Cutland, C. L., Gutu, K., Yun, J. A., Izu, A., Mahtab, S., Peter, J., Ansah, N. A., Obaro, S., Tilahun, B., Jambo, K., Sow, S., Kagucia, E. W., Chicumbe, S., Dlamini, T., Browne, M., Clothier, H., Griffin, J., Jiang, Y., Lee, A., Ghebreab, L., Madhi, S. A., & Black, S. B. (2025). Lessons learnt during establishment of COVID-19 active vaccine safety surveillance in nine African countries. Vaccine, 62, 127441. https://doi.org/10.1016/j.vaccine.2025.127441
  24. Das, R., Hossain, M. N., Levine, M. M., Kotloff, K. L., Nasrin, D., Hossain, M. J., Omore, R., Sur, D., Ahmed, T., Breiman, R. F., Faruque, A. S. G., & Freeman, M. C. (2025). Impact of water, sanitation, and hygiene indicators on enteric viral pathogens among under-5 children in low resource settings. Science of the Total Environment, 961, 178401. https://doi.org/10.1016/j.scitotenv.2025.178401
  25. Dashraath, P., Nielsen-Saines, K., Hui, L., Madhi, S. A., & Baud, D. (2025). The WHO Pandemic Agreement: Protecting pregnant people. The Lancet Obstetrics, Gynaecology & Women’s Health, 100026. Advance online publication. https://doi.org/10.1016/j.lanogw.2025.100026
  26. Dassaye E, Chetty T, Daniels B, Gaffoor Z, Spooner E, Ramraj T, Mthethwa N, Nsibande D, Pillay S, Bhana A, Magasana V, Reddy T, Mohlabi K, Moore PL, Burgers WA, de Oliveira T, Goga A. (2024) SARS-CoV-2 infections in a triad of primary school learners (grades 1-7), their parents and teachers in KwaZulu-Natal, South Africa: A pilot study protocol. Journal of Medical Internet Research Protocols, e52713
  27. Devar, J., Baichan, P., Mpangase, P. T., Elebo, N., Makan, A., Pincus, A., Lahoud, N., Cacciatore, S., Candy, G., Smith, M., & Nweke, E. E. (2025). Identification of differentially expressed genes and associated immune cell types in South African gallbladder cancer patients. Scientific Reports, 15, 39429. https://doi.org/10.1038/s41598-025-23056-1
  28. Devar, J., Elebo, N., Makan, A., Pincus, A., Lahoud, N., Cacciatore, S., Candy, G. P., Smith, M., & Nweke, E. E. (2025). Metabolomic and lipoprotein profiling of South African gall bladder cancer patients. HPB, 27, S362–S363. https://doi.org/10.1016/j.hpb.2025.04.621
  29. Devar, J., Elebo, N., Makan, A., Pincus, A., Lahoud, N., Cacciatore, S., Candy, G., Smith, M., & Nweke, E. E. (2025). Distinct metabolomic and lipoprotein signatures in gall bladder cancer patients of Black African ancestry. Cancers, 17(17), 2925. https://doi.org/10.3390/cancers17172925
  30. Dubazana, S., Ngwenya, S., Elebo, N., Mpangase, P., Ntwasa, M., Omoshoro-Jones, J., Naicker, P., Cacciatore, S., Buthelezi, S., & Nweke, E. E. (2025). Abstract A039: Multi-omic analyses of pancreatic ductal adenocarcinoma patients of African ancestry. Cancer Research, 85(18_Supplement_3), A039. https://doi.org/10.1158/1538-7445.PANCREATIC25-A039
  31. Dubazana, S., Nweke, E., Ngwenya, S., Naicker, P., Elebo, N., Buthelezi, S., & Omoshoro-Jones, J. O. (2025). Abstract A040: Multi-omic analyses of the tumour microenvironment of South African pancreatic ductal adenocarcinoma patients. Cancer Research, 85(18_Supplement_3), A040. https://doi.org/10.1158/1538-7445.PANCREATIC25-A040
  32. Fisher, L. H., Lazarus, E., Yu, C., Moodie, Z., Stieh, D. J., Yates, N., Zhang, L., Sawant, S., De Rosa, S. C., Cohen, K. W., Morris, D., Grant, S., Randhawa, A., Miner, M. D., Hendriks, J., Wegmann, F., Gill, K. M., Laher, F., Bekker, L. G., Gray, G. E., Corey, L., McElrath, M. J., Martin, T., Gilbert, P. B., Tomaras, G., Walsh, S. R., & Baden, L. R. (2025). ALVAC-prime and monomeric gp120 protein boost induces distinct HIV-1 specific humoral and cellular responses compared with adenovirus-prime and trimeric gp140 protein boost. PLOS Global Public Health, 5(3), Article e0004250. https://doi.org/10.1371/journal.pgph.0004250
  33. Garrett, N., Tapley, A., Hudson, A., Dadabhai, S., Zhang, B., Mgodi, N. M., Andriesen, J., Takalani, A., Fisher, L. H., Kee, J. J., Magaret, C. A., Villaran, M., Hural, J., Andersen-Nissen, E., Ferarri, G., Miner, M. D., Le Roux, B., Wilkinson, E., Lessells, R., de Oliveira, T., & Gray, G. (2025). Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. EClinicalMedicine, 80, 103054. https://doi.org/10.1016/j.eclinm.2024.103054
  34. Geffen, L., Besser, M., Goemaere, E., Gray, G., Lloyd Sherlock, P., Madhi, S., Manjra, S., Price, M., & Venter, F. (2025). Upholding medical ethics: A letter to the Israeli Medical Association. The Lancet, 389(10080), 1667–1668. https://doi.org/10.1016/S0140-6736(25)01662-9
  35. Gent, V., Dhar, N., Izu, A., Jones, S., Dangor, Z., Briner, C., Hosken, N., Kwatra, G., & Madhi, S. A. (2025). Association of serum anti-gbs2106 protein immunoglobulin G in newborns and risk reduction of invasive group B Streptococcus disease during early infancy. Vaccine, 54, 127016. https://doi.org/10.1016/j.vaccine.2025.127016
  36. Gieselmann L, DeLaitsch AT, Rohde M, Gruell H, Kreer C, Ervanoglu MS, Gristick HP, Schommers P, Ahmadov E, Radford C, Mazzolini A, Zhang L, West AP, Worczinski J, Momot A Reichwein ML, Knufer J, Stumpf R, Mkhize NN, Kaldine H, Bhebhe S, Deshpande S, Giovannoni D, Stefanutti E, Bengni F, Havenar-Daughton C, Corti D, Kroidl A, Adhikari A, Nanfack AJ, Ambada GE, Duerr R, Maganga L, William W, Ntinginya NE, Wolf T, Geldmacher C, Hoelscher M, Lehmann C, Moore PL, Mora T, Walczak AM, Gilbert PB, Doria-Rose NA, Huang Y, Bloom JD, Seaman MS, Bjorkman PJ, Klein F (2025). Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy. Nature Immunology (Published online )
  37. Gordhan, B. G., Sewcharran, A., Waja, Z., Martinson, N., Araujo-Pereira, M., Saboia, A. de S., Lourenço, M. C. S., Gomes-Silva, A., Rolla, V. C., & Kana, B. D., & Associative BRICS Research in Covid-19 and TB (ABRICOT) Research Group. (2025). Oral Rinse as an Alternative Diagnostic Specimen for Detection of Tuberculosis. American Journal of Respiratory and Critical Care Medicine, 211(11), 2136–2139. https://doi.org/10.1164/rccm.202503-0723RL
  38. Govender V, Reddy T, Maenetje P, Beattie T, Adonis T, Nielson T, Moodley J, Mdluli J, Bhoola A, Lawrence S, Panchia R, Mngadi K, Innes C, Brumskine W, Zwane ZD, Mlotshwa M, Nhlangulela L, Ncube I, Moyo-Gwete T, Moore PL, Keeton R, Burgers W, Garg N, Tripathi A, Taljaard M, Sayed S, Matsimela K, Mchunu N, Cox J, Wallis R, Koff W, Edward VA, Churchyard G on behalf of the COVID-19 Vaccine Strategies study group. (2025) Randomised trial of a single dose of Ad26.COV2.S, BNT162b2 or SARS-CoV-2-rS-Protein-Nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: safety and immunogenicity. Lancet HIV (In press)
  39. Gray, G. E., & Venter, W. D. F. (2025). Working at Cross-PURPOSEs to ending HIV. New England Journal of Medicine, 392(13), 1344–1345. https://doi.org/10.1056/NEJMe2414709
  40. Gray, G., Williamson, C., Bekker, L. G., Daniels, B., Smidt, W., Garrett, N., Kityo Mutuluuza, C., Mwesigwa, B., Stranix-Chibanda, L., Akimbu, A., Obuku, A., Johnson, T., Naluyima, P., Sawe, F., Burgers, W., Ntiginya, N., Morar, N., Takalani, A., Hendricks, S., Woeber, K., Abrahams, F., Tholanah, M., Mugamba, S., Mulder, M., & Moore, P. (2025). Africa is an essential partner in the research and development of an HIV vaccine. Current HIV Research, 23(3), 203–208. https://doi.org/10.2174/011570162X361496250627004203
  41. Hauner, A., Rogé, S., Vanlerberghe, V., Lepore, L., Ndayisenga, F., Shyaka, A., Van Esbroeck, M., Situma, S., Nasimiyu, C., Ahuka-Mundeke, S., Njenga, M. K., Breiman, R. F., Masumu, J., Mukadi-Bamuleka, D., & Ariën, K. K. (2025). Technical validation of a multiplex real-time PCR for combined detection of Rift Valley fever, chikungunya, Zika and dengue viruses. Journal of Virological Methods, 337, 115174. https://doi.org/10.1016/j.jviromet.2025.115174
  42. Hesselman MC, Zeeb M, Rusert P, Pasin C, Mamrosh J, Kariuki S, Pichler I, Sickmann M, Kaufmann MM, Schmidt D, Friedrich N, Metzner KJ, Rindler A, Kuster H, Adams C, Thebus R, Huber M,  Yerly S, Leuzinger K, Perreau M, Koller R, Dollenmaier G, Frigerio S, Westfall DH, Deng W,deCamp AC, Juraska M, Edupuganti S, Mgodi N, Murrell H, Garrett N, Wagh K, Mullins JI, Williamson C, Moore PL, Gùˆnthard HF, Kouyos RD, Trkola. (2025) Rare twin cysteine residues in the HIV-1 envelope variable region 1 link to neutralization escape and breadth development. Cell Host Microbe, 33(2):279-293.
  43. Ikuomola, F. I., Duckworth, C., Nweke, E. E., Turkson, J., Omoshoro-Jones, J. A. O., & Muganza, A. (2025). Exploring the tumour microenvironment (TME) in AIDS-defining cancers (ADC) and non-AIDS defining cancers (NADC) in the HIV population: Implications on remission, relapse and resistance. Stem Cell Reviews and Reports. Advance online publication. https://doi.org/10.1007/s12015-025-10997-3
  44. Iranzadeh, A., Alisoltani, A., Kiran, A. M., Breiman, R. F., Chaguza, C., Peno, C., Cornick, J. E., Everett, D. B., & Mulder, N. (2025). Comparative pangenomics of Streptococcus pneumoniae from Malawi: Uncovering genetic variability and pathogenicity. Microbial Genomics, 11(4). https://doi.org/10.1099/mgen.0.001370
  45. Ismail, N., Moultrie, H., Mwansa-Kambafwile, J., Copas, A, Izu, A., Moyo, S., Skinner, D., … Madhi, S. A. (2025). Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: A randomised controlled trial. The Lancet Infectious Diseases, 25(7), 764–774. https://doi.org/10.1016/S1473-3099(24)00816-8
  46. Izu, A., Mutsaerts, E. A., Olwagen, C., Jose, L., Koen, A., Nana, A. J., Cutland, C. L., & Madhi, S. A. (2025). Serotype-specific serum immunoglobulin G at 18 months of age following one or two doses of a primary series of 10-valent or 13-valent pneumococcal conjugate vaccine and a booster dose at nine months of age: A randomized controlled study. Expert Review of Vaccines, 24(1), 121–127. https://doi.org/10.1080/14760584.2025.2458179
  47. Jatt, L. P., Mgodi, N. M., Buchbinder, S. P., Gray, G. E., & Kublin, J. G. (2025). An HIV vaccine in the era of twice-yearly lenacapavir for PrEP - Essential or irrelevant? New England Journal of Medicine, 392(16), 1561–1563. https://doi.org/10.1056/NEJMp2415893
  48. Johnson, M. J., Lazarus, S. K., Bennett, A. E., Tovar-Salazar, A., Robertson, C. E., Kofonow, J. M., Li, S., … Weinberg, A. (2025). Gut microbiota and other factors associated with increased T cell regulation in HIV-exposed uninfected infants. Frontiers in Immunology, 16, 1533003. https://doi.org/10.3389/fimmu.2025.1533003
  49. Kadio, K., Congo, M., Sana, A., Filippi, V., Roos, N., Scorgie, F., Kovats, S., Nakstad, B., Gon, G., Chersich, M., Hess, J. J., & Kouanda, S. (2025). Intervention co-design to reduce the impact of heat exposure on pregnant and postpartum women and newborns in Burkina Faso. Health Policy and Planning, 40(7), 708–716. https://doi.org/10.1093/heapol/ciaf091
  50. Karani, A., Ombok, C., Situma, S., Breiman, R., Mureithi, M., Jaoko, W., Njenga, M. K., & Ngere, I. (2025). Low-level zoonotic transmission of Clade C MERS-CoV in Africa: Insights from scoping review and cohort studies in hospital and community settings. Viruses, 17(1), 125. https://doi.org/10.3390/v17010125
  51. Karuna, S., Laher, F., Dadabhai, S., Yu, P. C., Grove, D., Orrell, C., Makhema, J., Hosseinipour, M. C., Mathew, C. A., Brumskine, W., Mgodi, N., Andrew, P., Gama, L., Karg, C., Broder, G., Baepanye, K., Lucas, J., Andrasik, M., Takuva, S., Villaran, M., Takalani, A., Tressler, R., Soto-Torres, L., Woodward Davis, A. S., Dhai, A., Sanne, I. M., Cohen, M. S., Corey, L., Gray, G., deCamp, A. C., & Bar, K. J. (2025). Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data. Journal of the International AIDS Society, 28(2), Article e26495. https://doi.org/10.1002/jia2.26495
  52. Kenmogne, V. L., Takundwa, M. M., Nweke, E. E., Elebo, N., Mcintyre, J., Disenyane, D., Mashishi, B., & Dlamini, Z. (2025). The first-in-Africa ex vivo drug sensitivity testing platform identifies novel drug combinations for South African leukaemia patient cohort. Scientific Reports, 15, 9160. https://doi.org/10.1038/s41598-025-93634-w
  53. Kenny, A., van Duijn, J., Dintwe, O., Heptinstall, J., Burnham, R., Sawant, S., Zhang, L., Mielke, D., Khuzwayo, S., Omar, F. L., Stanfield-Oakley, S., Keyes, T., Dunn, B., Goodman, D., Fong, Y., Benkeser, D., Zou, R., Hural, J., Hyrien, O., Juraska, M., Luedtke, A., van der Laan, L., Giorgi, E. E., Magaret, C., Carpp, L. N., Pattacini, L., van de Kerkhof, T., Korber, B., Willems, W., Fisher, L. H., Schuitemaker, H., Swann, E., Kublin, J. G., Pau, M. G., Buchbinder, S., Tomaka, F., Nijs, S., Lavreys, L., Gelderblom, H. C., Corey, L., Mngadi, K., Gray, G. E., Borducchi, E., Hendriks, J., Seaton, K. E., Zolla-Pazner, S., Barouch, D. H., Ferrari, G., De Rosa, S. C., McElrath, M. J., Andersen-Nissen, E.1, Stieh, D. J., Tomaras, G. D., & Gilbert, P. B. (2025). Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine, 111, 105874. https://doi.org/10.1016/j.ebiom.2025.105874
  54. Kisenge, R. R., Godfrey, E., Ideh, R. C., Kamara, J., Coleman-Nekar, Y. J., Samma, A., Manji, H. K., Sudfeld, C. R., Westbrook, A., Niescierenko, M., Morris, C. R., Whitney, C. G., Breiman, R. F., Duggan, C. P., Manji, K. P., & Rees, C. A. (2025). Development and internal validation of a risk assessment tool to identify neonates at risk for 60-day hospital readmission in Dar es Salaam, Tanzania, and Monrovia, Liberia. American Journal of Tropical Medicine and Hygiene, 112(6), 1184–1191. https://doi.org/10.4269/ajtmh.24-0648
  55. Kistan, G., Sebitloane, M., Lombard, C., Godlwana, Z., Desmond, A. C., Clark, R., Rooney, J. F., Gray, G., & Moodley, D. (2025). Tenofovir disoproxil fumarate/emtricitabine prophylaxis has no effect on bone mineral density and bone mineral content in African breastfeeding women receiving pre-exposure prophylaxis for HIV. Journal of Acquired Immune Deficiency Syndromes, 98(3), 265–273. https://doi.org/10.1097/QAI.0000000000003563
  56. Lanata, C. F., Ochoa, T. J., Bancalari, E. M., Baylor, N. W., Edwards, K., Faden, R. R., Madhi, S. A., Nohynek, H., & Weijer, C. (2025). Testing an experimental vaccine during a public health emergency: Lessons from a Peruvian case. Vaccine, 56, 127176. https://doi.org/10.1016/j.vaccine.2025.127176
  57. Laney, E., Makhadi, S., Nweke, E. E., Elebo, N., & Moeng, M. S. (2025). Rib fractures: A review of presenting factors, associated injuries and outcomes at a level 1 trauma facility. Trauma Care, 5(4), 25. https://doi.org/10.3390/traumacare5040025
  58. Le Doare, K., Benassi, V., Cavaleri, M., Enwere, G., Giersing, B., Goldblatt, D., Heath, P., Hombach, J., Isbrucker, R., Karampatsas, K., Madhi, S. A., & Smith, A. W. (2025). Clinical and regulatory development strategies for GBS vaccines intended for maternal immunisation in low- and middle-income countries. Vaccine, 58, 127131. https://doi.org/10.1016/j.vaccine.2025.127131
  59. Lee, R., Hemingway-Foday, J., Batsuli, N., Wagner, L. D., Macoubray, A., Garry, R. F., Johnson, C. K., Hanley, K. A., Vasilakis, N., Mboup, S., Li, H., Sánchez, C. A., Rabinowitz, P. M., Breiman, R. F., Vandergrift, N., Earley, E. J., Bouton-Verville, H., Beaubien, E. C., Davidson, E. M., Van Vliet, G., Woodson, S., Moody, M. A., Sempowski, G. D., & Reithinger, R. (2025). Use of a pathogen X tabletop exercise to assess the operational response preparedness of an emerging infectious diseases research network. Frontiers in Public Health, 13, Article 1551996. https://doi.org/10.3389/fpubh.2025.1551996
  60. Machemedze, T., Kabudula, C. W., Bashingwa, J. J. H., Barr, B. A. T., Myburgh, N., Mahtab, S., Hwinya, C., Tollman, S., Dangor, Z., & Madhi, S. A. (2025). A retrospective assessment of COVID-19 vulnerability index indicators and mortality rates pre-COVID-19 (2018–2020) and during COVID-19 (2020–2022) in a health and demographic surveillance site, Soweto, South Africa. Population Health Metrics, 23(Suppl. 2), 28. https://doi.org/10.1186/s12963-025-00387-9
  61. Madhi, S. A., Ceballos, A., Cousin, L., Domachowske, J. B., Langley, J. M., Lu, E., Puthanakit, T., … Cohen, R. A. (2025). Population attributable risk of wheeze in 2- to <6-year-old children following a respiratory syncytial virus lower respiratory tract infection in the first 2 years of life. Pediatric Infectious Disease Journal, 44(5), 379–386. https://doi.org/10.1097/INF.0000000000004447
  62. Madhi, S. A., Kampmann, B., Simões, E. A. F., Zachariah, P., Pahud, B. A., Radley, D., Sarwar, U. N., … Munjal, I. (2025). Preterm birth frequency and associated outcomes from the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal trial of the bivalent respiratory syncytial virus prefusion F protein vaccine: Correction. Obstetrics & Gynecology, 145(6), e154. https://doi.org/10.1097/AOG.0000000000005947
  63. Madhi, S. A., Simões, E. A. F., Acevedo, A., Novoa Pizarro, J. M., Shepard, J. S., Railkar, R. A., Cao, X., … Sinha, A. (2025). A phase 1b/2a trial of a half-life extended respiratory syncytial virus neutralizing antibody, Clesrovimab, in healthy preterm and full-term infants. Journal of Infectious Diseases, 231(3), e478–e487. https://doi.org/10.1093/infdis/jiae581
  64. Madhi, S. A., Simões, E. A. F., Klein, N. P., Zareba, A., Dormitzer, P. R., Scott, D. A., Gurtman, A., Gruber, W. C., Jansen, K. U., Cooper, D., Cai, B., Schmoele-Thoma, B., & Swanson, K. A. (2025). Dynamics of respiratory syncytial virus illness and serology during pregnancy and infancy in the United States and South Africa. Open Forum Infectious Diseases, 12(7), ofaf386. https://doi.org/10.1093/ofid/ofaf386
  65. Mahomed S, Pillay K, Hassan-Moosa R, Galvao BPGV, Burgers WA, Moore PL, Abrahams M, Williamson C, Garrett N. (2025) Clinical Trials of Broadly Neutralizing Monoclonal Antibodies in People Living with HIV. AIDS Research and Therapy, 22: 44
  66. Mahomed, S., Beliveau, M., Heredia-Ortiz, R., Osman, F., Letsoalo, M., Capparelli, E. V., Garrett, N., Gengiah, T. B., Archary, D., Narpala, S., Castro, M., Serebryannyy, L., Carlton, K., Koup, R. A., Moore, P. L., Morris, L., Abdool Karim, Q., & Abdool Karim, S. S. (2025). Population Pharmacokinetics of weight-based compared to fixed dosing of CAP256V2LS, a Broadly Neutralizing Antibody for HIV Prevention in Women. Journal of Antimicrobial Chemotherapy, 80(8), 2135–2144.
  67. Makan-Murphy, N., Madhi, S. A., & Dangor, Z. (2025). Safety, efficacy, and effectiveness of maternal vaccination against respiratory infections in young infants. Seminars in Respiratory and Critical Care Medicine, 46(1), 1–13. https://doi.org/10.1055/a-2471-6906
  68. Makhadi, S., Mohlala, L., Nweke, E. E., Elebo, N., & Moeng, M. S. (2025). Video-assisted thoracoscopic surgery in a high-volume urban trauma centre. South African Journal of Surgery. https://doi.org/10.36303/SAJS.02692
  69. Malemela, K., Mangwana, N., Dias, S., Sharma, J. R., Ramharack, P., Kotze, A., van Onselen, R., Nkambule, S., Louw, J., Mdhluli, M., Gray, G., Muller, C., Mathee, A., Street, R., & Johnson, R. (2025). Upstream SARS-CoV-2 variant surveillance at Breede Valley municipality using wastewater-based epidemiology. Science of the Total Environment, 982, 179648. https://doi.org/10.1016/j.scitotenv.2025.179648
  70. Manamela, N. P., Motsoeneng, B. M., Spencer, H., Hermanus, T., Mzindle, N., Ayres, F., Makhado, Z., Serage, R., Gray, G., Bekker, L. G., Madhi, S. A., Moore, P. L., & Richardson, S. I. (2025). SARS-CoV-2 vaccines elicit differential Fc effector functions. iScience, 28(4), 113084. https://doi.org/10.1016/j.isci.2025.113084
  71. Masemola, N. M., Burnett, R. J., Makamba-Mutevedzi, P. C., Schönfeldt, M., Bamford, L. J., Ismail, Z., Madhi, S. A., & Meyer, J. C. (2025). Vaccine stock-outs: A preventable health facility obstacle contributing to missed vaccinations in South African children. Vaccine, 45, 126583. https://doi.org/10.1016/j.vaccine.2024.126583
  72. Matavele CR, Kwatra G, Ramgi P, Sigauque A, Khosa C, Viegas E, Bule O, Langa JP, Dhar N, Mukendi C, Langa D, Sevene E, Hermanus T, Manamela NP, RIchardson SI, Moore PL, Madhi SA, Jani I and the SIVCOV study group (2025). Hybrid immunity in a Mozambican cohort after one or two doses of the BBIBP-CorV vaccine. Clinical Infectious Diseases, 80:S57-S65
  73. McMahon, W. C., Kwatra, G., Nunes, M. C., Izu, A., Koen, A. L., Greffrath, J., Shalekoff, S., Tiemessen, C. T., Shinde, V., Bennett, C., & Madhi, S. A. (2025). T-cell responses induced by SARS-CoV-2 index-virus nanoparticle protein vaccine to the ancestral and omicron variants 6 months following primary vaccination. Communications Medicine, 5(1), 220. https://doi.org/10.1038/s43856-025-00941-4
  74. Mda, P., Mngadi, K., Zhang, B., Burnham, R., Juraska, M., Hyrien, O., Garrett, N., Dubula, T., Toni, S., Joseph, S., Kotze, P., Buchbinder, S., Takalani, A., Tomaka, F., Luedtke, A., Willems, W., Swann, E., Hutter, J., Gelderblom, H., McElrath, M. J., Stranix-Chibanda, L., Roxby, A. C., Bekker, L. G., & Gray, G. E. (2025). Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa. Frontiers in Reproductive Health, 7, Article 1565933. https://doi.org/10.3389/frph.2025.1565933
  75. Miyakawa, R., Zhang, H., Brooks, W. A., Prosperi, C., Baggett, H. C., Feikin, D. R., Hammitt, L. L., … Deloria Knoll, M. (2025). Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: The Pneumonia Etiology Research for Child Health (PERCH) study experience. Clinical Microbiology and Infection, 31(3), 441–450. https://doi.org/10.1016/j.cmi.2024.10.023
  76. Mkhize NN, Li SS, Hu J, Robinson ST, Hoosain Z, Garrett N, Chirenje ZM, Innes S, Kaldine H, Modise T, Moore PL, Randhawa AK, Sholuck A, Polakowski L, Corey L, Montefiori D, Janes H, Karuna S (2025. Neutralizing antibody responses over time in a demographically and clinically diverse cohort of individuals recovered from SARS-CoV-2 infection in Africa. PLoS Global Public Health, 5(9): e0005156.
  77. Mkhize NN, Zhang B, Bracket C, Elyanu PJ, Tapley A, Dadabhai S, Hu J, Omar FL, Do BTN, Schuster D, Heptinstall J, Sawant S, Seaton K, Sarzotti-Kelsoe M, Hudson A, Jin Y, Bhebhe S, Haajira K, Kgagudi P, Modise T, Mgodi MN, Andriesen J, Randhawa AK, Fisher LH, Kee JJ, Magaret CA, Peng J, Kenny A, Carpp LN, Chen Z, Heng S, Villaran M, Takalani A, le Roux B, Wilkiinson E, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samdari J, Chirenje Z, Makhema J, Kamuti E, Nuwagaba-Biribonwoha H, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delaney-Moretlwe S, Diacon AH, Fry S, Gill KM, Hoosain ZAE, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Kasaro M, Kassim P, Kayange N, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, McHarry K, Mitha E, Mngadi K, Mda P, Moloantoa T, Mutuluuza CK, Naicker N, Naicker V, Nana A, Nanvubya A, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Tayob MS, Vahed Y, Wabwire DO, Kublin JG, Bekker L, Corey L, Gray GE, Huang Y, Kotze P, Garrett N, Hural J, Ferrari G, Montefiori D, Moore PL, Andersen-Nissen E, McElrath MJ, Tomaras GD, Gilbert PB, for the CoVPN 3008 Study Team (2025). Neutralizing and Binding Antibody Immune Correlates Analysis of the CoVPN 3008 Study of mRNA-1273 Vaccination in People with HIV. Nature Communications, 16:8876 
  78. Mkhize, N. N., Zhang, B., Brackett, C., Elyanu, P. J., Tapley, A., Dadabhai, S., Hu, J., Do, B. T. N., Schuster, D. J., Heptinstall, J., Sawant, S., Seaton, K., Sarzotti-Kelsoe, M., Hudson, A., Jin, Y., Bhebhe, S., Kaldine, H., Kgagudi, P., Modise, T., Mgodi, N. M., Andriesen, J., Randhawa, A. K., Fisher, L. H., Kee, J. J., Magaret, C. A., Peng, J., Kenny, A., Carpp, L. N., Chen, Z., Heng, S., Villaran, M., Takalani, A., Le Roux, B., Wilkinson, E., Odhiambo, J., Shah, P., Polakowski, L., Yacovone, M., Samandari, T., Chirenje, Z., Makhema, J., Kamuti, E., Njekwa, K., Nuwagaba-Biribonwoha, H., Baguma, A., Badal-Faesen, S., Brumskine, W., Coetzer, S., Dawson, R., Delany-Moretlwe, S., Diacon, A. H., Fry, S., Gill, K., Madikida, A., Hoosain, Z. A. E., Hosseinipour, M. C., Inambao, M., Innes, C., Innes, S., Kalonji, D., Mwape, H., Kassim, P., Kamanga, M. C., Kilembe, W., Laher, F., Malahleha, M., Maluleke, V. L., Mboya, G., Madiega, P. A., McHarry, K., Mitha, E., Duki, Y., Mda, P., Moerane, M., Moloantoa, T., Nuwamanya, S., Mahomed, S., Naicker, V., Nana, A., Nanvubya, A., Kawoozo, B., Nchabeleng, M., Otieno, W., Potgieter, E. L., Potloane, D., Punt, Z., Said, J., Singh, Y., Kassim, S., van der Vendt, D., Tayob, M. S., Vahed, Y., Wabwire, D. O., Kublin, J. G., Bekker, L. G., Corey, L., Gray, G. E., Huang, Y., Kotze, P., Garrett, N., Hural, J., Ferrari, G., Andersen-Nissen, E., Montefiori, D., Moore, P. L., McElrath, M. J., Tomaras, G. D., & Gilbert, P. B. (2025). Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV. Nature Communications, 16(1), 5898. https://doi.org/10.1038/s41467-025-63948-4
  79. Mlotshwa, N. W., Nweke, E. E., Elebo, N., Mcintyre, J., Disenyane, D., Mashishi, B., & Dlamini, Z. (2025). An audit of extracorporeal membrane oxygenation outcomes in patients with low cardiac output syndrome at Charlotte Maxeke Johannesburg Academic Hospital, South Africa. South African Medical Journal, 115(6), 39–44. https://doi.org/10.7196/SAMJ.2025.v115i6.2341
  80. Mogire, R. M., Muriuki, J. M., Bayimenye, R. F., Mentzer, A. J., Chong, A., Gouveia, M. H., Bentley, A. R., … Atkinson, S. H. (2025). OSBPL11 is an African-specific locus associated with 25-hydroxyvitamin D concentrations and cardiometabolic health. medRxiv. Advance online publication. https://doi.org/10.1101/2025.05.27.25328359
  81. Mohamed S, Beliveau M, Heredia-Ortiz R, Osman F, Letsoalo M, Capparelli EV, Garrett N, Gengiah TB, Archary D, Narpala S, Castro M, Serebryannyy L, Carlton K, Koup RA, Moore PL, Morris L, Abdool Karim Q, Abdool Karim SS. (2025) Population Pharmacokinetics of weight-based compared to fixed dosing of CAP256V2LS, a Broadly Neutralizing Antibody for HIV Prevention in Women. Journal of Antimicrobial Chemotherapy, 80: 2135–2144
  82. Moodie, Z., Li, S. S., Giorgi, E. E., Williams, L. D., Dintwe, O., Carpp, L. N., Chen, S., Seaton, K. E., Sawant, S. S., Zhang, L., Heptinstall, J., Liu, S., Grunenberg, N., Tomaka, F., Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Ake, J. A., Vasan, S., Pantaleo, G., Frank, I., Baden, L. R., Goepfert, P. A., Keefer, M., Chirenje, M., Hosseinipour, M. C., Mngadi, K., Laher, F., Garrett, N., Bekker, L. G., De Rosa, S., Andersen-Nissen, E., Kublin, J. G., Lu, S., Gilbert, P. B., Gray, G. E., Corey, L., McElrath, M. J., & Tomaras, G. D. (2025). A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials. Emerging Microbes & Infections, 14(1), Article 2485317. https://doi.org/10.1080/22221751.2025.2485317
  83. Moore, P. L., Madhi, S. A., & Gray, G. (2025). The Africa COVID-19 legacy - Improved vaccinology for pandemic preparedness. Cell Host & Microbe, 33(11), 1815–1818. https://doi.org/10.1016/j.chom.2025.09.013
  84. Mosoane, B., Nweke, E. E., Elebo, N., Moyakhe, N., Nevondo, L., Mcintyre, J., Disenyane, D., Mashishi, B., Omonisi, A., & Dlamini, Z. (2025). Understanding pancreatic cancer: Pancreatic cancer research and innovation in Africa (1st ed.). CRC Press. https://doi.org/10.1201/9781003434551
  85. Mrubata, K. L., Bailie, V., Solomon, F., Izu, A., Ncube, M., Nunes, M. C., Dangor, Z., Madhi, S. A., Moore, D. P., & Verwey, C. (2025). Impact of respiratory syncytial virus and severe acute respiratory syndrome coronavirus 2 coinfection on clinical severity and outcomes among children hospitalized with lower respiratory tract infections in Soweto, South Africa. Pediatric Infectious Disease Journal, 44(2), 107–111. https://doi.org/10.1097/INF.0000000000004560
  86. Mushunje, P. K., Sovershaeva, E., Olwagen, C. P., Madhi, S., Odland, J. Ø., Ferrand, R. A., Nicol, M. P., Abotsi, R. E., & Dube, F. S. (2025). Weekly azithromycin for 48 weeks impacts nasopharyngeal microbial prevalence and Streptococcus pneumoniae serotypes in children with HIV-associated chronic lung disease. Scientific Reports, 15(1), 39175. https://doi.org/10.1038/s41598-025-23693-6
  87. Mutevedzi, P. C., Madewell, Z. J., Kotloff, K. L., Bassat, Q., Chirinda, P. J., Cossa, A. C. A., Xerinda, E. G., … CHAMPS Consortium. (2025). Use of minimally invasive tissue sampling to determine the contribution of diarrheal diseases to under-five mortality and associated co-morbidities and co-infections in children with fatal diarrheal diseases in Africa and Bangladesh. PLOS Global Public Health, 5(6), e0004772. https://doi.org/10.1371/journal.pgph.0004772
  88. Muwonge, H., Nasimiyu, C., Bakamutumaho, B., Elyanu, P., Joloba, M. L., Situma, S., Schieffelin, J., Gunn, B., Bai, S., Breiman, R. F., Ssewanyana, I., Nabadda, S., Lutwama, J., Tegen, Y., Muruta, A., Kirenga, B., Olaro, C., Aceng, J. R., Bosa, H. K., & Njenga, M. K. (2025). Long-term clinical sequelae among Sudan ebolavirus disease survivors 2 years post-infection: A matched cohort study. BMC Medicine, 23(1), 432. https://doi.org/10.1186/s12916-025-04271-z
  89. Nasreen, S., Jiang, Y., Lu, H., Lee, A., Cutland, C. L., Gentile, A., Giglio, N., … Kwong, J. C. (2025). Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: A multinational self-controlled case series study. Vaccine, 60, 127291. https://doi.org/10.1016/j.vaccine.2025.127291
  90. Ndlovu B, Gounder K, Zikhali N, Singh L, Ntshangase N, Gumede N, Millar J, Mabuka J, Dong KL, Walker BD, Moore PL, Goulder PJR, Ndung'u T. (2025). Distinct neutralization sensitivity between adult and infant transmitted/ founder HIV-1 subtype C viruses to broadly neutralizing monoclonal antibodies. PLoS Pathogens, 21(6):e1013245
  91. Odinoh, R., Dawa, J., Situma, S., Nyakarahuka, L., Lepore, L., Vanlerberghe, V., Nasimiyu, C., Makiala, S., Ifufa, C., Mukadi, D., Viala, H., Owor, N., Bakamutumaho, B., Ndumu, D., Masumu, J., Breiman, R. F., & Njenga, K. (2025). Have you heard of Rift Valley fever? Findings from a multi-country study in East and Central Africa. PLOS One, 20(7), Article e0327398. https://doi.org/10.1371/journal.pone.0327398
  92. Olwagen, C. P., Izu, A., Khan, S., Van der Merwe, L., Dean, N. J., Mabena, F. C., Jones, S., … Madhi, S. A. (2025). Genomic relatedness of colonizing and invasive disease Klebsiella pneumoniae isolates in South African infants. Scientific Reports, 15(1), 8043. https://doi.org/10.1038/s41598-025-92517-4
  93. Omole, T. E., Nguyen, H. M., Marcinow, A., Oo, M. M., Jahan, N., Ssemaganda, A., Severini, G., Thomas, K. K., Celum, C., Mugo, N., Mujugira, A., Kublin, J., Corey, L., Sivro, A., Lingappa, J. R., Gray, G., & McKinnon, L. R. (2025). Pre-Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T cells and HIV risk among heterosexual individuals in Africa. The Journal of Infectious Diseases, 231(4), e770–e780. https://doi.org/10.1093/infdis/jiae638
  94. Omore, R., Ogwel, B., Ochieng, J. B., Juma, J., Omballa, V., Ouma, A., Aol, G., Audi, A., Agogo, G. O., Odongo, G., Onyango, C., Wamola, N., Komo, T., Chepkemoi, D., Hunsperger, E., Feikin, D. R., Montgomery, J. M., Widdowson, M., Prentice-Mott, G., Mintz, E. D., Breiman, R. F., Munywoki, P. K., Bigogo, G. M., & Verani, J. R. (2025). Population-based incidence and antimicrobial susceptibility patterns of shigellosis among children and adults from rural and urban Kenya, 2010–2019. medRxiv. Advance online publication. https://doi.org/10.1101/2025.08.12.25337299
  95. Patel F, Le Roux J, Sawry S, Kieser R, Dhar M, Gill K, Lazarus EM, Nana A, Garrett N, Moore PL, Sigal A, Gray G, Rees HV, Jacobson B, Fairlie L. (2025) Clot Twist – D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS. South African Medical Journal, 11:5  
  96. Pillay, K., Khan, Z. A., Nweke, E. E., & Omoshoro-Jones, J. (2024). Clinicopathological presentation of liver abscesses and hydatid liver disease from two South African tertiary hospitals. World Journal of Hepatology, 16(12), 1417–1428. https://doi.org/10.4254/wjh.v16.i12.1417
  97. Rahman, A., Lee, K. H., Arifeen, S. E., Hossain, M. Z., Chowdhury, A. I., Alam, M., Afrin, A., Ogbuanu, I. U., Samura, S., Kaluma, E., Ojulong, J., Sow, S., Keita, A. M., Tapia, M. D., Chawla, K. K., Kotloff, K., Madhi, S. A., Mahtab, S., Adam, Y., Wise, A., Dangor, Z., Mugah, C., Oele, E., Omore, R., Igunza, A. K., Onyango, D., Mandomando, I., Bassat, Q., Ajanovic, S., Varo, R., Xerinda, E., Assefa, N., Scott, J. A. G., Madrid, L., Yeshi, M. M., Temesgen, F., Liu, L., Mutevedzi, P., Blau, D. M., Akelo, V., Breiman, R. F., Whitney, C. G., & Gurley, E. S. (2025). Causes of stillbirth in sub-Saharan Africa and South Asia: Findings from Child Health and Mortality Prevention Surveillance, 2016–2023. medRxiv. Advance online publication. https://doi.org/10.1101/2025.09.12.25338198
  98. Rahman, A., Ray, M., Madewell, Z. J., Igunza, K. A., Akelo, V., Onyango, D., Murila, F., … Child Health and Mortality Prevention Surveillance (CHAMPS) Network. (2025). Adherence to perinatal asphyxia or sepsis management guidelines in low- and middle-income countries. JAMA Network Open, 8(5), e2510790. https://doi.org/10.1001/jamanetworkopen.2025.10790
  99. Rovetini, L., Belciug, G. F., Massai, L., Nonne, F., Alfini, R, Ranchod, H., Reddy, D. L., … Rossi, O. (2025). Development and characterization of a ten-plex assay to measure Klebsiella pneumoniae antigen-specific IgG in human sera. Methods and Protocols, 8(3), 52. https://doi.org/10.3390/mps8030052
  100. Samadari T, Achola M, Hutter JN, Mboya G, Otieno W, Kee JJ, Huang Y, Aponte JJ, Ockenhouse CF, Lee CK, Polakowski L, Yacovone M, Tapley A, Dadabhai S, Mhize NN, Haajira K, Bhebhe S, Moore PL, Hural J, Garrett N, Kublin JG (2025). Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults. Journal of Infectious Diseases (Published online)
  101. Seale, A. C., Kebede, M., Glazik, R., Brhane, M., Berihun, M., Teklemariam, Z., Marami, D., Oundo, J., Gure, T., Tesfaye, T., Karanu, A., Wilson, G., Obiero, C. W., Blau, D. M., Barsosio, H., Koech, A., Saha, S., Lawn, J. E., Breiman, R. F., Gordon, N. C., Wittmann, S., Madrid, L., Aseffa, A., Dessie, Y., Berkley, J. A., Assefa, N., & Scott, J. A. G. (2025). Effect of maternal infection on stillbirths and early neonatal deaths: Nested case-control studies in pregnancy cohorts in East Africa. medRxiv. Advance online publication. https://doi.org/10.1101/2025.09.24.25338421
  102. Sherman, A. C., Gray, G. E., Cao, B., To, K. K. W., Rouphael, N., Henao-Restrepo, A. M., Gordon, A. C., & Baden, L. R. (2025). Acute SARS-CoV-2 infection. Nature Reviews Disease Primers, 11(1), 75. https://doi.org/10.1038/s41572-025-00662-x
  103. Simões, E. A. F., Pahud, B. A., Madhi, S. A., Kampmann, B., Shittu, E., Radley, D., Llapur, C., … MATISSE Clinical Trial Group. (2025). Efficacy, safety, and immunogenicity of the MATISSE (Maternal Immunization Study for Safety and Efficacy) maternal respiratory syncytial virus prefusion F protein vaccine trial. Obstetrics & Gynecology, 145(2), 157–167. https://doi.org/10.1097/AOG.0000000000005816
  104. Singh P, Mlambo T, Bloom K, Mussolino C, Arbuthnot P, Ely A. Generating mRNA Encoding Anti-HBV Designer Epigenome Modifiers. Methods Mol Biol. 2025;2965:323-339. doi: 10.1007/978-1-0716-4742-4_15
  105. Smith T, Singh P, Bhana R, Kairuz D, Bloom K, Maepa MB, Ely A, Arbuthnot P. Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice. Viruses. 2025 Aug 7;17(8):1090. doi: 10.3390/v17081090.
  106. Spracklen T, Day Jonathan, van der Ross H, Butters C, Benede NSB, Walters A, Bunjun R, Moyo-Gwete T, Madzivhandila M, Mendelsohn SC, Scriba TJ, Shey M, Burgers WA, Moore PL, Zuhlke LJ, Keeton R, Webb K. (2025) Humoral, T cell and immune gene expression responses to SARS-CoV-2 vaccination in a small group of children with previous MIS-C. Vaccine, 62: 127451
  107. Stanberry, L. R., Makadzange, T., James, W. G., Dietrich, J. J., Hotez, P. J., Madhi, S. A., Rosenthal, S. L., … Leask, J. (2025). Proposal for a fourth indicator on vaccine uptake in the joint external evaluation tool. Bulletin of the World Health Organization, 103(3), 226–228. https://doi.org/10.2471/BLT.24.292086
  108. Sutar J, Jayal P, Mullick R, Chaudhary S, Kamble P, Bhowmick S,Kitchin D, Kaldine H, Mkhize NN, Ndlovu B, Gounder K, Mukherjee S, Srivas S, Sharma N, Prasad C, Tweatia S, Parihar N, Kumar N, Kasarpalkar N, Singh B, Mohaptra S, Aquil M, Kumar CV, Dinesha TR, Srikrishnan AK, Shastri J, Mondal S, Bandopadhyay B, Guha SK, Kale D, Biswas D, Patil D, Paranjape RS, Kondapi A, Bhor V, Deshpande S, Sok D, Ndung’u, Moore PL, Murugavel KG, Patel V, Bhattacharya J. (2025) Distinct region-specific neutralization profiles of contemporary HIV-1 clade C viruses against best in class broadly neutralizing antibodies. Journal of Virology, 99(6):e0000825  [
  109. Tan, R., Chandna, A., Colbourn, T., Hooli, S., King, C., Lufesi, N., McCollum, E. D., … World Health Organization PREPARE study group. (2025). Development and validation of a novel clinical risk score to predict hypoxaemia in children with pneumonia using the WHO PREPARE dataset. BMJ Global Health, 10(7), e017256. https://doi.org/10.1136/bmjgh-2024-017256
  110. van de Perre P, Moore PL, Gama L, Moles JP. (2025) Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission? AIDS, 39(7):918-920
  111. Van Dorsten, R. T., & Breiman, R. (2025). A landscape review with novel criteria to evaluate microbial drivers for cancer: Priorities for innovative research targeting excessive cancer mortality in sub-Saharan Africa. Frontiers in Cellular and Infection Microbiology, 15, Article 1625818. https://doi.org/10.3389/fcimb.2025.1625818
  112. Velaphi, S., Madewell, Z. J., Tippett-Barr, B., Blau, D. M., Rogena, E. A., Lala, S. G., Mahtab, S., … Madhi, S. A. (2025). Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling. Clinical Infectious Diseases. Advance online publication. https://doi.org/10.1093/cid/ciaf098
  113. Venter, M., Manuguerra, J. C., Alviola, P. A., et al. (2025). A WHO global framework to guide investigations into origins of potentially epidemic and pandemic pathogens. Nature Communications, 16(1), 2122. https://doi.org/10.1038/s41467-025-57218-6
  114. Violari, A., Otwombe, K., Hahn, W., Chen, S., Josipovic, D., Baba, V., Angelidou, A., Smolen, K. K., Levy, O., Mkhize, N. N., Woodward Davis, A. S., Martin, T. M., Haynes, B. F., Williams, W. B., Sagawa, Z. K., Kublin, J. G., Polakowski, L., Brewinski Isaacs, M., Yen, C., Tomaras, G., Corey, L., Janes, H., & Gray, G. E. (2025). Safety and implementation of phase 1 randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns. The Journal of Clinical Investigation, 135(8), e186927. https://doi.org/10.1172/jci186927
  115. Vyas, K. J., Muir, J. A., Madewell, Z. J., Gupta, P. M., Blau, D. M., Arifeen, S. E., Gurley, E. S., … CHAMPS Network. (2025). Major causes of perinatal and paediatric mortality in sub-Saharan Africa and South Asia: Adjustment for selection bias in the CHAMPS Network. Paediatric and Perinatal Epidemiology. Advance online publication. https://doi.org/10.1111/ppe.70067
  116. Zar, H. J., Simões, E. A. F., Madhi, S. A., Ramilo, O., Senders, S. D., Shepard, J. S., Laoprasopwattana, K., … CLEVER (MK-1654-004) Study Group. (2025). Clesrovimab for prevention of RSV disease in healthy infants. The New England Journal of Medicine, 393(13), 1292–1303. https://doi.org/10.1056/NEJMoa2502984
Publications 2024
  1. Akullian A, Akulu R, Aliyu G, Anam F, Guichard AC, Ayles H, Baggaley R, Bansi-Matharu L, Baptiste SL, Bershteyn A, Cambiano V, Carter A, Chotun N, Citron DT, Crowley S, Dalal S, Edun O, Fraser C, Galvani AP, Garnett GP, Glabius R, Godfrey-Faussett P, Grabowski MK, Gray GE, Hargreaves JR, Imai-Eaton JW, Johnson LF, Kaftan D, Kagaayi J, Kataika E, Kilonzo N, Kirungi WL, Korenromp EL, Kouton MH, Lucie Abeler-Dörner L, Mahy M, Mangal TD, Martin-Hughes R, Matsikure S, Meyer-Rath G, Mishra S, Mmelesi M, Mohammed A, Moolla H, Morrison MR, Moyo S, Mudimu E, Mugabe M, Murenga M, Ng'ang'a J, Olaifa Y, Phillips AN, Pickles MREH, Probert WJM, Ramaabya D, Rautenbach SP, Revill P, Shakarishvili A, Sheneberger R, Smith J, Stegling C, Stover J, Tanser F, Taramusi I, ten Brink D, Whittles LK, Zaidi I, The Post HIVRWG. The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa. The Lancet. 2024;404(10453):638. 
  2. Bassat Q, Blau DM, Ogbuanu IU, Samura S, Kaluma E, Bassey IA, Sow S, Keita AM, Tapia MD, Mehta A, Kotloff KL, Rahman A, Islam KM, Alam M, El Arifeen S, Gurley ES, Baillie V, Mutevedzi P, Mahtab S, Thwala BN, Tippett Barr BA, Onyango D, Akelo V, Rogena E, Onyango P, Omore R, Mandomando I, Ajanovic S, Varo R, Sitoe A, Duran-Frigola M, Assefa N, Scott JAG, Madrid L, Tesfaye T, Dessie Y, Madewell ZJ, Breiman RF, Whitney CG, Madhi SA, Child Health and Mortality Prevention Surveillance (CHAMPS) Network. Causes of Death Among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network.  JAMA Netw Open. 2023 Jul 3;6(7):e2322494. doi: 10.1001/jamanetworkopen.2023.22494.PMID: 37494044
  3. Beyrer C, Tomaras GD, Gelderblom HC, Gray GE, Janes HE, Bekker LG, Millett G, Pantaleo G, Buchbinder S, Corey L. Is HIV epidemic control by 2030 realistic? The Lancet HIV. 2024;11(7):e489-e94. DOI: 10.1016/S2352-3018(24)00098-5
  4. Bisanzio D, Kyobe Bosa H, Bakamutumaho B, Nasimiyu C, Atwine D, Kyabayinze D, Olaro C, Breiman RF, Njenga MK, Mwebesa H, Aceng JR, Reithinger R. 2022 Sudan Ebolavirus Outbreak in Uganda: Modelling Case Burden and Outbreak Duration. medRxiv [Preprint]. 2024 Oct 11:2024.10.11.24314870. doi: 10.1101/2024.10.11.24314870. PMID: 39417149; PMCID: PMC11483010
  5. Breiman RF, Demetriou G, Naidu G, Papathanasopoulos MA, Ruff P, Madhi SA. Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research.  PLOS Glob Public Health. 2023 May 31;3(5):e0001970. doi: 10.1371/journal.pgph.0001970. eCollection  2023.PMID: 37256858
  6. Carpp LN, Hyrien O, Fong Y, Benkeser D, Roels S, Stieh DJ, Van Dromme I, Van Roey GA, Kenny A, Huang Y, Carone M, McDermott AB, Houchens CR, Martins K, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Petropoulos CJ, Luedtke A, Lu Y, Yu C, Juraska M, Hejazi NS, Wolfe DN, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Bekker LG, Gaur AH, Veloso VG, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Vandebosch A, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Follmann D, Koup RA, Donis RO, Gilbert PB. Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial. Nat Commun. 2024;15(1):9785. Epub 2024/11/13. DOI: 10.1038/s41467-024-53727-y.
  7. Cates J, Powell H, Platts-Mills J, Nasrin D, Panchalingam S, Sow SO, Traore A, Sur D, Ramamurthy T, Zaidi AKM, Kabir F, Faruque ASG, Ahmed D, Breiman RF, Omore R, Ochieng JB, Hossain MJ, Antonio M, Mandomando I, Vubil D, Nataro JP, Levine MM, Parashar UD, Kotloff KL, Tate JE.  Clinical severity of enteric viruses detected using a quantitative molecular assay compared to conventional assays in the Global Enteric Multicenter Study.  J Infect Dis. 2024 Apr 18:jiae201. doi: 10.1093/infdis/jiae201
  8. Chihana R, Jin Kee J, Moodie Z, Huang Y, Janes H, Dadabhai S, Roxby AC, Allen M, Kassim S, Naicker V, Innes C, Naicker N, Dubula T, Grunenberg N, Malahleha M, Kublin JG, Bekker LG, Gray G, Kumwenda J, Laher F. Factors associated with reactogenicity to an investigational HIV vaccine regimen in HIV vaccine trials network 702. Vaccine. 2024;42(20). DOI: 10.1016/j.vaccine.2024.05.039
  9. Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M, Scriba TJ, Seddon JA, Tisile P, Warner DF, Wilkinson RJ, Esmail H, Houben RMGJ, Alland D, Behr MA, Beko BB, Burhan E, Churchyard G, Cobelens F, Denholm JT, Dinkele R, Ellner JJ, Fatima R, Haigh KA, Hatherill M, Horton KC, Kendall EA, Khan PY, MacPherson P, Malherbe ST, Mave V, Mendelsohn SC, Musvosvi M, Nemes E, Penn-Nicholson A, Ramamurthy D, Rangaka MX, Sahu S, Schwalb A, Shah DK, Sheerin D, Simon D, Steyn AJC, Thu Anh N, Walzl G, Weller CL, Williams CM, Wong EB, Wood R, Xie YL, Yi S, International Consensus for Early TBg. Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise. The Lancet Respiratory Medicine. 2024;12(6):484-98. DOI: 10.1016/S2213-2600(24)00028-6
  10. Das R, Haque MA, Kotloff KL, Nasrin D, Hossain MJ, Sur D, Ahmed T, Levine MM, Breiman RF, Faruque ASG, Freeman MC. Enteric viral pathogens and child growth among under-five children: findings from South Asia and sub-Saharan Africa. Sci Rep. 2024 Jun 15;14(1):13871. doi: 10.1038/s41598-024-64374-0. PMID: 38879558
  11. Das R, Palit P, Haque MA, Levine MM, Kotloff KL, Nasrin D, Hossain MJ, Sur D, Ahmed T, Breiman RF, Freeman MC, Faruque ASG.  Symptomatic and asymptomatic enteric protozoan parasitic infection and their association with subsequent growth parameters in under five children in South Asia and sub-Saharan Africa. PLoS Negl Trop Dis. 2023 Oct 10;17(10):e0011687. doi: 10.1371/journal.pntd.0011687. Online ahead of print.PMID: 37816031
  12. Fisher LH, Kee JJ, Liu A, Espinosa CM, Randhawa AK, Ludwig J, Magaret CA, Robinson ST, Gilbert PB, Hyrien O, Kublin JG, Rouphael N, Falsey AR, Sobieszczyk ME, El Sahly HM, Grinsztejn B, Gray GE, Kotloff KL, Gay CL, Leav B, Hirsch I, Struyf F, Dunkle LM, Neuzil KM, Corey L, Huang Y, Goepfert PA, Walsh SR, Baden LR, Janes H. SARS-CoV-2 Viral Load in the Nasopharynx at Time of First Infection Among Unvaccinated Individuals: A Secondary Cross-Protocol Analysis of 4 Randomized Trials. JAMA Network Open. 2024;7(5). DOI: 10.1001/jamanetworkopen.2024.12835
  13. Garcia Gomez E, Igunza KA, Madewell ZJ, Akelo V, Onyango D, El Arifeen S, Gurley ES, Hossain MZ, Chowdhury MAI, Islam KM, Assefa N, Scott JAG, Madrid L, Tilahun Y, Orlien S, Kotloff KL, Tapia MD, Keita AM, Mehta A, Magaço A, Torres-Fernandez D, Nhacolo A, Bassat Q, Mandomando I, Ogbuanu I, Cain CJ, Luke R, Kamara SIB, Legesse H, Madhi S, Dangor Z, Mahtab S, Wise A, Adam Y, Whitney CG, Mutevedzi PC, Blau DM, Breiman RF, Tippett Barr BA, Rees CA; Child Health and Mortality Prevention Surveillance Network. Identifying delays in healthcare seeking and provision: The Three Delays-in-Healthcare and mortality among infants and children aged 1-59 months. PLOS Glob Public Health. 2024 Feb 8;4(2):e0002494. doi: 10.1371/journal.pgph.0002494. eCollection 2024.PMID: 38329969
  14. Garrett N, Dintwe O, Monaco CL, Jones M, Seaton KE, Church EC, Grunenberg N, Hutter J, deCamp A, Huang Y, Lu H, Mann P, Robinson ST, Heptinstall J, Jensen RL, Pantaleo G, Ding S, Koutsoukos M, Hosseinipour MC, van der Meeren O, Gilbert PB, Ferrari G, Andersen-Nissen E, McElrath MJ, Tomaras GD, Gray GE, Corey L, Kublin JG, Hvtn, Teams HS. Safety and Immunogenicity of a DNA Vaccine With Subtype C gp120 Protein Adjuvanted With MF59 or AS01B: A phase 1/2a HIV-1 vaccine trial. Journal of Acquired Immune Deficiency Syndromes. 2024;96(4):350-60. DOI: 10.1097/QAI.0000000000003438
  15. Garrett N, Reddy T, Yende-Zuma N, Takalani A, Woeber K, Bodenstein A, Jonas P, Engelbrecht I, Jassat W, Moultrie H, Bradshaw D, Seocharan I, Odhiambo J, Khuto K, Richardson SI, Omondi MA, Nesamari R, Keeton RS, Riou C, Moyo-Gwete T, Innes C, Zwane Z, Mngadi K, Brumskine W, Naicker N, Potloane D, Badal-Faesen S, Innes S, Barnabas S, Lombaard J, Gill K, Nchabeleng M, Snyman E, Petrick F, Spooner E, Naidoo L, Kalonji D, Naicker V, Singh N, Maboa R, Mda P, Malan D, Nana A, Malahleha M, Kotze P, Allagappen JJ, Diacon AH, Kruger GM, Patel F, Moore PL, Burgers WA, Anteyi K, Leav B, Bekker LG, Gray GE, Goga A. Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study. PLOS Glob Public Health. 2024;4(12):e0003260. Epub 2024/12/05. DOI: 10.1371/journal.pgph.0003260. PubMed PMID: 39636838; PubMed Central PMCID: PMCPMC11620404 company. The other authors declare no conflict of interests.
  16. Gray GE, Mngadi K, Lavreys L, Nijs S, Gilbert PB, Hural J, Hyrien O, Juraska M, Luedtke A, Mann P, McElrath MJ, Odhiambo JA, Stieh DJ, van Duijn J, Takalani AN, Willems W, Tapley A, Tomaras GD, Van Hoof J, Schuitemaker H, Swann E, Barouch DH, Kublin JG, Corey L, Pau MG, Buchbinder S, Tomaka F, Allagappen J, Andriesen J, Ayres A, Bekker LG, Borremans C, Brumskine W, Chilengi R, Dubula T, Garrett N, Gelderblom H, Gill K, Hoosain Z, Hosseinipour M, Hutter J, Inambao M, Innes C, Kilembe W, Kotze P, Kotze S, Laher F, Laszlo I, Lazarus E, Malahleha M, Mathebula M, Matoga M, McClennen R, Mda P, Meerts P, Naicker V, Naidoo L, Philip T, Pitsi A, Scheppler L, Sopher C, Takuva SG, Viegas E, Weijtens M, Yuan O, Imbokodo HHPXSG. Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial. The Lancet Infectious Diseases. 2024. DOI: 10.1016/S1473-3099(24)00358-X.
  17. Huang, Y., Alam, S., Andersen-Nissen, E., Carpp, L. N., Dintwe, O. B., Flach, B. S., Grunenberg, N., Laher, F., De Rosa, S. C., Ferrari, G., Innes, C., Bekker, L. G., Kublin, J. G., McElrath, M. J., Tomaras, G. D., Gray, G. E., & Gilbert, P. B. (2024). Non-HIV Vaccine-Induced Immune Responses as Potential Baseline Immunogenicity Predictors of ALVAC-HIV and AIDSVAX B/E-Induced Immune Responses. Viruses, 16(9), 1365. https://doi.org/10.3390/v16091365. PubMed PMID: 39339842; PubMed Central PMCID: PMCPMC11437453.
  18. Janes H, Fisher LH, Kee JJ, Parameswaran L, Goepfert PA, Falsey AR, Ludwig J, Magaret CA, Gilbert PB, Kublin JG, Rouphael N, Sobieszczyk ME, El Sahly HM, Baden LR, Grinsztejn B, Walsh SR, Gray GE, Kotloff KL, Gay CL, Greninger AL, Tapia MD, Hammershaimb EA, Priddy FH, Green JA, Struyf F, Dunkle L, Neuzil KM, Corey L, Huang Y. Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials. J Infect Dis. 2024;230(6):1384-9. Epub 2024/09/03. DOI: 10.1093/infdis/jiae400. PubMed PMID: 39225478; PubMed Central PMCID: PMCPMC11646576
  19. Jaumdally S, Tomasicchio M, Pooran A, Esmail A, Kotze A, Meier S, Wilson L, Oelofse S, van der Merwe C, Roomaney A, Davids M, Suliman T, Joseph R, Perumal T, Scott A, Shaw M, Preiser W, Williamson C, Goga A, Mayne E, Gray G, Moore P, Sigal A, Limberis J, Metcalfe J, Dheda K. Frequency, kinetics and determinants of viable SARS-CoV-2 in bioaerosols from ambulatory COVID-19 patients infected with the Beta, Delta or Omicron variants. NATURE COMMUNICATIONS. 2024;15(1). DOI: 10.1038/s41467-024-45400-1. PubMed PMID: WOS:001180394600008
  20. Javaid N, Lo SW, Nisar MI, Basharat A, Jaleel H, Rasool K, Sultana Q, Kabir F, Hotwani A, Breiman RF, Bentley SD, Shakoor S, Mirza S. Strain features of pneumococcal isolates in the pre- and post-PCV10 era in Pakistan. Microb Genom. 2024 Jan;10(1). doi: 10.1099/mgen.0.001163.PMID: 38270581 
  21. Kanyoka P, Barnabas S, Bekker LG, Bruisten S, Bunjun R, Dabee S, Gamieldien H, Gill K, Gray G, Jaspan H, Kullin B, Lewis D, Muller E, Passmore JA, Versteeg B. Diversity in sequence types of Chlamydia trachomatis and inflammatory profiles in adolescent girls and young women from Cape Town and Johannesburg, South Africa. SEXUALLY TRANSMITTED DISEASES. 2024;51(1):S81-S2. PubMed PMID: WOS:001145322900100
  22. Kenny A, van Duijn J, Dintwe O, Heptinstall J, Burnham R, Sawant S, Zhang L, Mielke D, Khuzwayo S, Omar FL, Stanfield-Oakley S, Keyes T, Dunn B, Goodman D, Fong Y, Benkeser D, Zou R, Hural J, Hyrien O, Juraska M, Luedtke A, van der Laan L, Giorgi EE, Magaret C, Carpp LN, Pattacini L, van de Kerkhof T, Korber B, Willems W, Fisher LH, Schuitemaker H, Swann E, Kublin JG, Pau MG, Buchbinder S, Tomaka F, Nijs S, Lavreys L, Gelderblom HC, Corey L, Mngadi K, Gray GE, Borducchi E, Hendriks J, Seaton KE, Zolla-Pazner S, Barouch DH, Ferrari G, De Rosa SC, McElrath MJ, Andersen-Nissen E, Stieh DJ, Tomaras GD, Gilbert PB. Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study. EBioMedicine. 2024;108:105320. Epub 2024/09/06. DOI: 10.1016/j.ebiom.2024.105320. PubMed PMID: 39236556; PubMed Central PMCID: PMCPMC11404224.
  23. Kisenge R, Ideh RC, Kamara J, Coleman-Nekar YG, Samma A, Godfrey E, Manji HK, Sudfeld CR, Westbrook A, Niescierenko M, Morris CR, Whitney CG, Breiman RF, Duggan CP, Manji KP, Rees CA.   Morbidity and unplanned healthcare encounters after hospital discharge among young children in Dar es Salaam, Tanzania and Monrovia, Liberia.  BMJ Paediatr Open. 2024 Jun 21;8(1):e002613. doi: 10.1136/bmjpo-2024-002613.PMID: 38906561 
  24. Kyobe Bosa H, Njenga MK, Wayengera M, Kirenga B, Muttamba W, Dawa J, Breiman RF, Osoro E, Ngere I, Omaswa F, Okware S, Kabanda R, Mwebesa H, Atwine D, Woldemariam YT, Aceng JR.  Leveraging the structures of the COVID-19 pandemic response for successful control of Ebola in Uganda.  Nat Med. 2023 Jun 23. doi: 10.1038/s41591-023-02395-4. Online ahead of print.PMID: 37353647 
  25. Legoabe Z, Sebitloane M, Lombard C, Naidoo M, Gray G, Moodley D. Development of normal reference intervals for renal function in pregnancy: a secondary analysis of clinical trial data. Journal of Obstetrics and Gynaecology. 2024;44(1). DOI: 10.1080/01443615.2024.2361445.
  26. Leulseged H, Bethencourt C, Igunza KA, Akelo V, Onyango D, Omore R, Ogbuanu IU, Ameh S, Moseray A, Kowuor D, Bassey IA, El Arifeen S, Gurley ES, Hossain MZ, Rahman A, Alam M, Assefa N, Madrid L, Alemu A, Abdullahi YY, Kotloff KL, Sow SO, Tapia MD, Kourouma N, Sissoko S, Bassat Q, Varo R, Mandomando I, Carrilho C, Rakislova N, Fernandes F, Madhi S, Dangor Z, Mahtab S, Hale M, Baillie V, du Toit J, Madewell ZJ, Blau DM, Martines RB, Mutevedzi PC, Breiman RF, Whitney CG, Rees CA; Child Health and Mortality Prevention Surveillance (CHAMPS) network.  Clinicopathological discrepancies in the diagnoses of childhood causes of death in the CHAMPS network: An analysis of antemortem diagnostic inaccuracies.  BMJ Paediatr Open. 2024 Jul 20;8(1):e002654. doi: 10.1136/bmjpo-2024-002654.PMID: 39032935
  27. Lo SW, Hawkins PA, Jibir B, Hassan-Hanga F, Gambo M, Olaosebikan R, Olanipekun G, Munir H, Kocmich N, Rezac-Elgohary A, Gambo S, Bagenda D, Fey P, Breiman RF, McGee L, Bentley SD, Obaro SK, Community Acquired Pneumonia And Invasive Bacterial Disease Capibd Consortium.  Molecular characterization of Streptococcus pneumoniae causing disease among children in Nigeria during the introduction of PCV10 (GSK).  Microb Genom. 2023 Sep;9(9). doi: 10.1099/mgen.0.001094.PMID: 37712828 
  28. Madrid L, Alemu A, Seale AC, Oundo J, Tesfaye T, Marami D, Yigzaw H, Ibrahim A, Degefa K, Dufera T, Teklemariam Z, Gure T, Leulseged H, Wittmann S, Abayneh M, Fentaw S, Temesgen F, Yeshi MM, Dubale M, Girma Z, Ackley C, Damisse B, Breines M, Orlien SMS, Blau DM, Breiman RF, Abate E, Dessie Y, Assefa N, Scott JAG; CHAMPS Ethiopia Study Group. Causes of stillbirth and death among children younger than 5 years in eastern Hararghe, Ethiopia: a population-based post-mortem study. Lancet Glob Health. 2023 Jun 1:S2214-109X(23)00211-5. doi: 10.1016/S2214-109X(23)00211-5. Online ahead of print.PMID: 37271163
  29. Magaço A, Alonso Y, Maixenchs M, Ambrosio C, Sitoe A, Vitorino P, Blau D, Garel M, Breiman R, Amouzou A, Bassat Q, Mandomando I, Blevins J, Munguambe K. A Qualitative Assessment of Community Acceptability and Its Determinants in the Implementation of Minimally Invasive Tissue Sampling in Children in Quelimane City, Mozambique.  2023 Apr 10:tpmd220343. doi: 10.4269/ajtmh.22-0343
  30. Magaço A, Maixenchs M, Macete Y, Escritório N, Mucor R, Calia A, Sitoe A, Xirinda E, Vitorino P, Garel M, Breiman RF, Amouzou A, Bassat Q, Mandomando I, Blevins J, Munguambe K. Experiences of parents and caretakers going through the consent process to perform minimally invasive tissue sampling (MITS) on their deceased children in Quelimane, Mozambique: A qualitative study.  PLoS One. 2023 Jun 9;18(6):e0286785. doi: 10.1371/journal.pone.0286785. eCollection 2023.PMID: 37294780 
  31. Magaret CA, Li L, deCamp AC, Rolland M, Juraska M, Williamson BD, Ludwig J, Molitor C, Benkeser D, Luedtke A, Simpkins B, Heng F, Sun Y, Carpp LN, Bai H, Dearlove BL, Giorgi EE, Jongeneelen M, Brandenburg B, McCallum M, Bowen JE, Veesler D, Sadoff J, Gray GE, Roels S, Vandebosch A, Stieh DJ, Le Gars M, Vingerhoets J, Grinsztejn B, Goepfert PA, de Sousa LP, Silva MST, Casapia M, Losso MH, Little SJ, Gaur A, Bekker LG, Garrett N, Truyers C, Van Dromme I, Swann E, Marovich MA, Follmann D, Neuzil KM, Corey L, Greninger AL, Roychoudhury P, Hyrien O, Gilbert PB. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features. Nature Communications. 2024;15(1). DOI: 10.1038/s41467-024-46536-w
  32. Mahtab S, Blau DM, Madewell ZJ, Ogbuanu I, Ojulong J, Lako S, Legesse H, Bangura JS, Bassat Q, Mandomando I, Xerinda E, Fernandes F, Varo R, Sow SO, Kotloff KL, Tapia MD, Keita AM, Sidibe D, Onyango D, Akelo V, Gethi D, Verani JR, Revathi G, Scott JAG, Assefa N, Madrid L, Bizuayehu H, Tirfe TT, El Arifeen S, Gurley ES, Islam KM, Alam M, Zahid Hossain M, Dangor Z, Baillie VL, Hale M, Mutevedzi P, Breiman RF, Whitney CG, Madhi SA; CHAMPS Consortium. Post-mortem investigation of deaths due to pneumonia in children aged 1-59 months in sub-Saharan Africa and South Asia from 2016 to 2022: an observational study. Lancet Child Adolesc Health. 2024 Jan 25:S2352-4642(23)00328-0. doi: 10.1016/S2352-4642(23)00328-0
  33. Mahtab S, Madhi SA, Baillie VL, Els T, Thwala BN, Onyango D, Tippet-Barr BA, Akelo V, Igunza KA, Omore R, Arifeen SE, Gurley ES, Alam M, Chowdhury AI, Rahman A, Bassat Q, Mandomando I, Ajanovic S, Sitoe A, Varo R, Sow SO, Kotloff KL, Badji H, Tapia MD, Traore CB, Ogbuanu IU, Bunn J, Luke R, Sannoh S, Swarray-Deen A, Assefa N, Scott JAG, Madrid L, Marami D, Fentaw S, Diaz MH, Martines RB, Breiman RF, Madewell ZJ, Blau DM, Whitney CG; CHAMPS Consortium.  Causes of death identified in neonates enrolled through Child Health and Mortality Prevention Surveillance (CHAMPS), December 2016 -December 2021. PLOS Glob Public Health. 2023 Mar 20;3(3):e0001612. doi: 10.1371/journal.pgph.0001612. 
  34. Marks F, Im J, Park SE, Pak GD, Jeon HJ, Wandji Nana LR, Phoba MF, Mbuyi-Kalonji L, Mogeni OD, Yeshitela B, Panzner U, Cruz Espinoza LM, Beyene T, Owusu-Ansah M, Twumasi-Ankrah S, Yeshambaw M, Alemu A, Adewusi OJ, Adekanmbi O, Higginson E, Adepoju A, Agbi S, Cakpo EG, Ogunleye VO, Tunda GN, Ikhimiukor OO, Mbuyamba J, Toy T, Agyapong FO, Osei I, Amuasi J, Razafindrabe TJL, Raminosoa TM, Nyirenda G, Randriamampionona N, Seo HW, Seo H, Siribie M, Carey ME, Owusu M, Meyer CG, Rakotozandrindrainy N, Sarpong N, Razafindrakalia M, Razafimanantsoa R, Ouedraogo M, Kim YJ, Lee J, Zellweger RM, Kang SSY, Park JY, Crump JA, Hardy L, Jacobs J, Garrett DO, Andrews JR, Poudyal N, Kim DR, Clemens JD, Baker SG, Kim JH, Dougan G, Sugimoto JD, Van Puyvelde S, Kehinde A, Popoola OA, Mogasale V, Breiman RF, MacWright WR, Aseffa A, Tadesse BT, Haselbeck A, Adu-Sarkodie Y, Teferi M, Bassiahi AS, Okeke IN, Lunguya-Metila O, Owusu-Dabo E, Rakotozandrindrainy R. Incidence of typhoid fever in Burkina Faso, Democratic Republic of the Congo, Ethiopia, Ghana, Madagascar, and Nigeria (the Severe Typhoid in Africa programme): a population-based study Lancet Glob Health. 2024 Apr;12(4):e599-e610. doi: 10.1016/S2214-109X(24)00007-X.PMID: 38485427 
  35. Naidoo M, Naidoo KL, Lombard C, Desmond AC, Clark R, Rooney JF, Gray G, Moodley D. In-utero exposure to tenofovir disoproxil fumarate pre-exposure prophylaxis and growth metrics in HIV unexposed breastfed infants in South Africa: a post hoc analysis of the CAP 016 PrEP in pregnancy RCT. Frontiers in Pediatrics. 2024;12. DOI: 10.3389/fped.2024.1447173
  36. Ng'eno E, Lind M, Audi A, Ouma A, Oduor C, Munywoki PK, Agogo GO, Odongo G, Kiplangat S, Wamola N, Osita MP, Mugoh R, Ochieng C, Omballa V, Mogeni OD, Mikoleit M, Fields BS, Montgomery JM, Gauld J, Breiman RF, Juma B, Hunsperger E, Widdowson MA, Bigogo G, Mintz ED, Verani JR. Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010-2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya. Am J Trop Med Hyg. 2023 May 30:tpmd220736. doi: 10.4269/ajtmh.22-0736. Online ahead of print. PMID: 37253442
  37. Nowak KD, Lane MA, Mbanya A, Carter JR, Binion BA, Espinoza DO, Collins MH, Heaney CD, Pisanic N, Kruczynski K, Spicer K, Rivera MG, Glover F, Ojo-Akosile T, Breiman RF, Anderson EJ, Lobelo F, Fairley JK. High SARS-CoV-2 secondary infection rates in households with children in Georgia, United States, Fall 2020-Winter 2021. Front Public Health. 2024 Oct 25;12:1378701. doi: 10.3389/fpubh.2024.1378701. PMID: 39525464; PMCID: PMC11544598
  38. Oduor C, Omwenga I, Ouma A, Mutinda R, Kiplangat S, Mogeni OD, Cosmas L, Audi A, Odongo GS, Obor D, Breiman R, Montgomery J, Agogo G, Munywoki P, Bigogo G, Verani JR.  Mortality patterns over a 10-year period in Kibera, an urban informal settlement in Nairobi, Kenya, 2009-2018.  Glob Health Action. 2023 Dec 31;16(1):2238428. doi: 10.1080/16549716.2023.2238428.PMID: 37490025 
  39. Post HIVRWGEajhhe, Post HIVRWG. The HIV response beyond 2030: preparing for decades of sustained HIV epidemic control in eastern and southern Africa. Lancet. 2024;404(10453):638-41. Epub 2024/05/24. DOI: 10.1016/S0140-6736(24)00980-2. PubMed PMID: 38782003.
  40. Reddy K, Naidoo KL, Lombard C, Godlwana Z, Desmond AC, Clark R, Rooney JF, Gray G, Moodley D. In-utero exposure to tenofovir-containing pre-exposure prophylaxis and bone mineral content in HIV-unexposed infants in South Africa. J Int AIDS Soc. 2024;27(11):e26379. Epub 2024/11/13. DOI: 10.1002/jia2.26379. PubMed PMID: 39528419; PubMed Central PMCID: PMCPMC11554427
  41. Rees CA, Ideh RC, Kisenge R, Kamara J, Coleman-Nekar YG, Samma A, Godfrey E, Manji HK, Sudfeld CR, Westbrook AL, Niescierenko M, Morris CR, Whitney CG, Breiman RF, Duggan CP, Manji KP. Identifying neonates at risk for post-discharge mortality in Dar es Salaam, Tanzania, and Monrovia, Liberia: Derivation and internal validation of a novel risk assessment tool. BMJ Open. 2024 Feb 15;14(2):e079389. doi: 10.1136/bmjopen-2023-079389. PMID: 38365298
  42. Rees CA, Igunza KA, Madewell ZJ, Akelo V, Onyango D, El Arifeen S, Gurley ES, Hossain MZ, Rahman A, Alam M, Scott JAG, Assefa N, Madrid L, Belachew A, Leulseged H, Kotloff KL, Sow SO, Tapia MD, Keita AM, Sidibe D, Sitoe A, Varo R, Ajanovic S, Bassat Q, Mandomando I, Tippett Barr BA, Ogbuanu I, Cain CJ, Bassey IA, Luke R, Gassama K, Madhi S, Dangor Z, Mahtab S, Velaphi S, du Toit J, Mutevedzi PC, Blau DM, Breiman RF, Whitney CG; Child Health and Mortality Prevention Surveillance Network.  Provider adherence to clinical care recommendations for infants and children who died in seven low- and middle-income countries in the Child Health and Mortality Prevention Surveillance (CHAMPS) network. EClinicalMedicine. 2023 Aug 31;63:102198. doi: 10.1016/j.eclinm.2023.102198. eCollection 2023 Sep. PMID: 37692079
  43. Rees CA, Kisenge R, Godfrey E, Ideh RC, Kamara J, Coleman-Nekar YJ, Samma A, Manji HK, Sudfeld CR, Westbrook A, Niescierenko M, Morris CR, Whitney CG, Breiman RF, Duggan CP, Manji KP. Derivation and Internal Validation of a Novel Risk Assessment Tool to Identify Infants and Young Children at Risk for Post-Discharge Mortality in Dar es Salaam, Tanzania and Monrovia, Liberia. J Pediatr. 2024 Jun 13:114147. doi: 10.1016/j.jpeds.2024.114147. PMID: 38878962
  44. Rees CA, Kisenge R, Ideh RC, Kamara J, Coleman YJ, Samma A, Godfrey E, Manji HK, Sudfeld CR, Westbrook AL, Niescierenko M, Morris CR, Whitney CG, Breiman RF, Manji KP, Duggan CP.  Predictive value of clinician impression for readmission and postdischarge mortality among neonates and young children in Dar es Salaam, Tanzania and Monrovia, Liberia.  BMJ Paediatr Open. 2023 Jun;7(1):e001972. doi: 10.1136/bmjpo-2023-001972.PMID: 37385735
  45. Riou C, Bhiman JN, Ganga Y, Sawry S, Ayres F, Baguma R, Balla SR, Benede N, Bernstein M, Besethi AS, Cele S, Crowther C, Dhar M, Geyer S, Gill K, Grifoni A, Hermanus T, Kaldine H, Keeton RS, Kgagudi P, Khan K, Lazarus E, Le Roux J, Lustig G, Madzivhandila M, Magugu SFJ, Makhado Z, Manamela NP, Mkhize Q, Mosala P, Motlou TP, Mutavhatsindi H, Mzindle NB, Nana A, Nesamari R, Ngomti A, Nkayi AA, Nkosi TP, Omondi MA, Panchia R, Patel F, Sette A, Singh U, van Graan S, Venter EM, Walters A, Moyo-Gwete T, Richardson SI, Garrett N, Rees H, Bekker LG, Gray G, Burgers WA, Sigal A, Moore PL, Fairlie L. Safety and immunogenicity of booster vaccination and fractional dosing with Ad26. COV2.S or BNT162b2 in Ad26.COV2.Svaccinated participants. PLOS Global Public Health. 2024;4(4). DOI: 10.1371/journal.pgph.0002703
  46. Rowji P, Seocharan I, Reddy T, Yende-Zuma N, Khutho K, Sanne I, Bekker LG, Gray G, Garrett N, Goga A. Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine. 2024;42(6):1195-9. Epub 2024/01/27. DOI: 10.1016/j.vaccine.2024.01.066. PubMed PMID: 38278629
  47. Salmon DA, Dudley MZ, Brewer J, Shaw J, Schuh HB, Proveaux TM, Jamison AM, Forr A, Goryn M, Breiman RF, Orenstein WA, Kao LS, Josiah Willcock R, Cantu M, Decea T, Mowson R, Tsubata K, Bucci LM, Lawler J, Watkins JD, Moore JW, Fugett JH, Fugal A, Tovar Y, Gay M, Cary AM, Vann I, Smith LB, Kan L, Mankel M, Beekun S, Smith V, Adams SD, Harvey SA, Orton PZ. LetsTalkShots: personalized vaccine risk communication.  Front Public Health. 2023 Jun 30;11:1195751. doi: 10.3389/fpubh.2023.1195751. eCollection 2023.PMID: 37457264
  48. Schuh HB, Rimal RN, Breiman RF, Orton PZ, Dudley MZ, Kao LS, Sargent RH, Laurie S, Weakland LF, Lavery JV, Orenstein WA, Brewer J, Jamison AM, Shaw J, Josiah Willock R, Gust DA, Salmon DA.  Evaluation of online videos to engage viewers and support decision-making for COVID-19 vaccination: how narratives and race/ethnicity enhance viewer experiences.  Front Public Health. 2023 Aug 21;11:1192676. doi: 10.3389/fpubh.2023.1192676. eCollection 2023.PMID: 37670826 
  49. Sherman AC, Tuan J, Cantos VD, Adeyiga O, Mahoney S, Ortega-Villa AM, Tillman A, Whitaker J, Woodward Davis AS, Leav B, Hirsch I, Sadoff J, Dunkle LM, Gilbert PB, Janes HE, Kublin JG, Goepfert PA, Kotloff K, Rouphael N, Falsey AR, El Sahly HM, Sobieszczyk ME, Huang Y, Neuzil KM, Corey L, Grinsztejn B, Gray G, Nason M, Baden LR, Gay CL. COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials. Clinical Infectious Diseases. 2024;79(2):364-74. DOI: 10.1093/cid/ciae192. PubMed PMID: WOS:001219728700001
  50. Situma, S., Omondi, E., Nyakarahuka, L., Odinoh, R., Mweu, M., Mureithi, M. W., Mulinge, M. M., Clancey, E., Dawa, J., Ngere, I., Osoro, E., Gunn, B., Konongoi, L., Khamadi, S. A., Michiels, J., Ariën, K. K., Bakamutumaho, B., Breiman, R. F., & Njenga, K. (2024). Serological evidence of cryptic Rift Valley Fever virus transmission among humans and livestock in Central Highlands of Kenya. Viruses, 16(12), 1927. https://doi.org/10.3390/v16121927
  51. Steenkamp L, Collie S, Moultrie TA, Moultrie H, Gray G. Death trends for 2010 - 2022 for members of a large private medical scheme in South Africa. South African Medical Journal. 2024;114(7):27-33. DOI: 10.7196/SAMJ.2024.v114i7.1597
  52. Street R, Mathee A, Reddy T, Mahlangeni NT, Mangwana N, Nkambule S, Webster C, Dias S, Sharma JR, Ramharack P, Louw J, Surujlal-Naicker S, Berkowitz N, Mdhluli M, Gray G, Muller C, Johnson R. One Year of Wastewater Surveillance in South Africa Supporting COVID-19 Clinical Findings Across Two Waves of Infection. Microorganisms. 2024;12(11). Epub 2024/11/27. DOI: 10.3390/microorganisms12112230. PubMed PMID: 39597619; PubMed Central PMCID: PMCPMC11596097
  53. Takalani, A., Robinson, M., Jonas, P., Bodenstein, A., Sambo, V., Jacobson, B., Louw, V., Opie, J., Peter, J., Rowji, P., Seocharan, I., Reddy, T., Yende-Zuma, N., Khutho, K., Sanne, I., Bekker, L. G., Gray, G., Garrett, N., Goga, A., & Sisonke Study Team (2024). Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa. Vaccine, 42(6), 1195–1199. https://doi.org/10.1016/j.vaccine.2024.01.066
  54. Van de Perre P, Scarlatti G, Moore PL, Molès JP, Nagot N, Tylleskär T, Gray G, Goga A. Preventing breast milk HIV transmission using broadly neutralizing monoclonal antibodies: One size does not fit all. Immunity, Inflammation and Disease. 2024;12(3). DOI: 10.1002/iid3.121
  55. Verani JR, Blau DM, Gurley ES, Akelo V, Assefa N, Baillie V, Bassat Q, Berhane M, Bunn J, Cossa ACA, El Arifeen S, Gunturu R, Hale M, Igunza A, Keita AM, Kenneh S, Kotloff KL, Kowuor D, Mabunda R, Madewell ZJ, Madhi S, Madrid L, Mahtab S, Miguel J, Murila FV, Ogbuanu IU, Ojulong J, Onyango D, Oundo JO, Scott JAG, Sow S, Tapia M, Traore CB, Velaphi S, Whitney CG, Mandomando I, Breiman RF. Child deaths caused by Klebsiella pneumoniae in sub-Saharan Africa and south Asia: a secondary analysis of Child Health and Mortality Prevention Surveillance (CHAMPS) data. Lancet Microbe. 2024 Jan 10:S2666-5247(23)00290-2. doi: 10.1016/S2666-5247(23)00290-2. Online ahead of print
  56. Verani JR, Omondi D, Odoyo A, Odiembo H, Ouma A, Ngambi J, Aol G, Audi A, Kiplangat S, Agumba N, Munywoki PK, Onyango C, Hunsperger E, Farrar JL, Kim L, Kobayashi M, Breiman RF, Pimenta FC, da Gloria Carvalho M, Lessa FC, Whitney CG, Bigogo G. Long-term impact of 10-valent pneumococcal conjugate vaccine in Kenya: Nasopharyngeal carriage among children in a rural and an urban site six years after introduction. Vaccine. 2024 Jul 13:S0264-410X(24)00782-5. doi: 10.1016/j.vaccine.2024.07.021. Online ahead of print. PMID: 39004525
  57. Williamson, C., Dyason, K., McNamara, C. et al. “The Learning of Learned ‘Learning Organizations’?”: How Southern African Universities Use a Professional Competency Framework for Research Management and Administration: Selective Cases. Syst Pract Action Res 37, 229–249 (2024). https://doi.org/10.1007/s11213-023-09660-0
  58. Williamson, C., Dyason, K., McNamara, C., Aslanyan, G. (2024) Extending professionalization boundaries in Research Management, Journal of Research Administration, 55 (2) 7-26.
Publications 2023
  1. Bassat, Q., Blau, D. M., Ogbuanu, I. U., Samura, S., Kaluma, E., Bassey, I. A., Sow, S., Keita, A. M., Tapia, M. D., Mehta, A., Kotloff, K. L., Rahman, A., Islam, K. M., Alam, M., el Arifeen, S., Gurley, E. S., Baillie, V., Mutevedzi, P., Mahtab, S., … Madhi, S. A. (2023). Causes of Death among Infants and Children in the Child Health and Mortality Prevention Surveillance (CHAMPS) Network. JAMA Network Open, 6(7). https://doi.org/10.1001/jamanetworkopen.2023.22494
  2. Breiman, R. F., Demetriou, G., Naidu, G., Papathanasopoulos, M. A., Ruff, P., & Madhi, S. A. (2023a). Shifting the center of gravity for addressing the rising cancer disease burden in Africa: A rationale for African-based integrative infectious diseases and oncology research. PLOS Global Public Health, 3(5). https://doi.org/10.1371/journal.pgph.0001970
  3. Das, R., Palit, P., Haque, M. A., Levine, M. M., Kotloff, K. L., Nasrin, D., Hossain, M. J., Sur, D., Ahmed, T., Breiman, R. F., Freeman, M. C., & Faruque, A. S. G. (2023). Symptomatic and asymptomatic enteric protozoan parasitic infection and their association with subsequent growth parameters in under five children in South Asia and sub-Saharan Africa. PLoS Neglected Tropical Diseases, 17(10 October). https://doi.org/10.1371/journal.pntd.0011687
  4. Hawkins, P. A., Chochua, S., Lo, S. W., Belman, S., Antonio, M., Kwambana-Adams, B., Gottberg, A. von, Plessis, M. du, Cornick, J., Beall, B., Breiman, R. F., Bentley, S. D., & McGee, L. (2023). A global genomic perspective on the multidrug-resistant Streptococcus pneumoniae 15A-CC63 sub-lineage following pneumococcal conjugate vaccine introduction. Microbial Genomics, 9(4). https://doi.org/10.1099/mgen.0.000998
  5. Kyobe Bosa, H., Njenga, M. K., Wayengera, M., Kirenga, B., Muttamba, W., Dawa, J., Breiman, R. F., Osoro, E., Ngere, I., Omaswa, F., Okware, S., Kabanda, R., Mwebesa, H., Atwine, D., Woldemariam, Y. T., & Aceng, J. R. (2023). Leveraging the structures of the COVID-19 pandemic response for successful control of Ebola in Uganda. In Nature Medicine (Vol. 29, Issue 8). https://doi.org/10.1038/s41591-023-02395-4
  6. Lo, S. W., Hawkins, P. A., Jibir, B., Hassan-Hanga, F., Gambo, M., Olaosebikan, R., Olanipekun, G., Munir, H., Kocmich, N., Rezac-Elgohary, A., Gambo, S., Bagenda, D., Fey, P., Breiman, R. F., McGee, L., Bentley, S. D., Obaro, S. K., Haruna, Z. A., Ibrahim, S. A., … Shehu, H. K. (2023). Molecular characterization of streptococcus pneumoniae causing disease among children in nigeria during the introduction of pcv10 (Gsk). Microbial Genomics, 9(9). https://doi.org/10.1099/mgen.0.001094
  7. Madrid, L., Alemu, A., Seale, A. C., Oundo, J., Tesfaye, T., Marami, D., Yigzaw, H., Ibrahim, A., Degefa, K., Dufera, T., Teklemariam, Z., Gure, T., Leulseged, H., Wittmann, S., Abayneh, M., Fentaw, S., Temesgen, F., Yeshi, M. M., Dubale, M., … Getnet, F. (2023). Causes of stillbirth and death among children younger than 5 years in eastern Hararghe, Ethiopia: a population-based post-mortem study. The Lancet Global Health, 11(7). https://doi.org/10.1016/S2214-109X(23)00211-5
  8. Magaço, A., Alonso, Y., Maixenchs, M., Ambrosio, C., Sitoe, A., Vitorino, P., Blau, D., Garel, M., Breiman, R., Amouzou, A., Bassat, Q., Mandomando, I., Blevins, J., & Munguambe, K. (2023). A Qualitative Assessment of Community Acceptability and Its Determinants in the Implementation of Minimally Invasive Tissue Sampling in Children in Quelimane City, Mozambique. American Journal of Tropical Medicine and Hygiene, 108. https://doi.org/10.4269/ajtmh.22-0343
  9. Magaço, A., Maixenchs, M., Macete, Y., Escritório, N., Mucor, R., Calia, A., Sitoe, A., Xirinda, E., Vitorino, P., Garel, M., Breiman, R. F., Amouzou, A., Bassat, Q., Mandomando, I., Blevins, J., & Munguambe, K. (2023). Experiences of parents and caretakers going through the consent process to perform minimally invasive tissue sampling (MITS) on their deceased children in Quelimane, Mozambique: A qualitative study. PLoS ONE, 18(6 JUNE). https://doi.org/10.1371/journal.pone.0286785
  10. Mahtab, S., Madhi, S. A., Baillie, V. L., Els, T., Thwala, B. N., Onyango, D., Tippet-Barr, B. A., Akelo, V., Igunza, K. A., Omore, R., el Arifeen, S., Gurley, E. S., Alam, M., Chowdhury, A. I., Rahman, A., Bassat, Q., Mandomando, I., Ajanovic, S., Sitoe, A., … Shiraz, I. (2023). Causes of death identified in neonates enrolled through Child Health and Mortality Prevention Surveillance (CHAMPS), December 2016 –December 2021. PLOS Global Public Health, 3(3). https://doi.org/10.1371/journal.pgph.0001612
  11. Ng’eno, E., Lind, M., Audi, A., Ouma, A., Oduor, C., Munywoki, P. K., Agogo, G. O., Odongo, G., Kiplangat, S., Wamola, N., Osita, M. P., Mugoh, R., Ochieng, C., Omballa, V., Mogeni, O. D., Mikoleit, M., Fields, B. S., Montgomery, J. M., Gauld, J., … Verani, J. R. (2023). Dynamic Incidence of Typhoid Fever over a 10-Year Period (2010-2019) in Kibera, an Urban Informal Settlement in Nairobi, Kenya. American Journal of Tropical Medicine and Hygiene, 109(1). https://doi.org/10.4269/ajtmh.22-0736
  12. Oduor, C., Omwenga, I., Ouma, A., Mutinda, R., Kiplangat, S., Mogeni, O. D., Cosmas, L., Audi, A., Odongo, G. S., Obor, D., Breiman, R., Montgomery, J., Agogo, G., Munywoki, P., Bigogo, G., & Verani, J. R. (2023). Mortality patterns over a 10-year period in Kibera, an urban informal settlement in Nairobi, Kenya, 2009–2018. Global Health Action, 16(1). https://doi.org/10.1080/16549716.2023.2238428
  13. Rees, C. A., Igunza, K. A., Madewell, Z. J., Akelo, V., Onyango, D., el Arifeen, S., Gurley, E. S., Hossain, M. Z., Rahman, A., Alam, M., Scott, J. A. G., Assefa, N., Madrid, L., Belachew, A., Leulseged, H., Kotloff, K. L., Sow, S. O., Tapia, M. D., Keita, A. M., … Bhandari, M. (2023). Provider adherence to clinical care recommendations for infants and children who died in seven low- and middle-income countries in the Child Health and Mortality Prevention Surveillance (CHAMPS) network. EClinicalMedicine, 63. https://doi.org/10.1016/j.eclinm.2023.102198
  14. Rees, C. A., Kisenge, R., Ideh, R. C., Kamara, J., Coleman, Y. J., Samma, A., Godfrey, E., Manji, H. K., Sudfeld, C. R., Westbrook, A. L., Niescierenko, M., Morris, C. R., Whitney, C. G., Breiman, R. F., Manji, K. P., & Duggan, C. P. (2023). Predictive value of clinician impression for readmission and postdischarge mortality among neonates and young children in Dar es Salaam, Tanzania and Monrovia, Liberia. BMJ Paediatrics Open, 7(1). https://doi.org/10.1136/bmjpo-2023-001972
  15. Salmon, D. A., Dudley, M. Z., Brewer, J., Shaw, J., Schuh, H. B., Proveaux, T. M., Jamison, A. M., Forr, A., Goryn, M., Breiman, R. F., Orenstein, W. A., Kao, L. S., Josiah Willcock, R., Cantu, M., Decea, T., Mowson, R., Tsubata, K., Bucci, L. M., Lawler, J., … Orton, P. Z. (2023). LetsTalkShots: personalized vaccine risk communication. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1195751
  16. Schuh, H. B., Rimal, R. N., Breiman, R. F., Orton, P. Z., Dudley, M. Z., Kao, L. S., Sargent, R. H., Laurie, S., Weakland, L. F., Lavery, J. v., Orenstein, W. A., Brewer, J., Jamison, A. M., Shaw, J., Josiah Willock, R., Gust, D. A., & Salmon, D. A. (2023). Evaluation of online videos to engage viewers and support decision-making for COVID-19 vaccination: how narratives and race/ethnicity enhance viewer experiences. Frontiers in Public Health, 11. https://doi.org/10.3389/fpubh.2023.1192676
Older publications
  1. Gupte, A. N., Wong, M. L., Msandiwa, R., Barnes, G. L., Golub, J., Chaisson, R. E., Hoffmann, C. J., & Martinson, N. A. (2017). Factors associated with pulmonary impairment in HIV-infected South African adults. PLoS ONE, 12(9). https://doi.org/10.1371/journal.pone.0184530
  2. Dwolatzky, B., Trengove, E., Struthers, H., McIntyre, J. A., & Martinson, N. A. (2006). Linking the global positioning system (GPS) to a personal digital assisstant (PDA) to support tuberculosis control in South Africa: A pilot study. International Journal of Health Geographics, 5. https://doi.org/10.1186/1476-072X-5-34
Share